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This project will produce an automated microfluidic system capable of extracting 
and purifying nucleic acids from raw samples for detection and analysis.  The first step 
will be the development and characterization of microfluidic components and fabrication 
methods that will be implemented into the final device.  The gas permeability properties 
of PDMS will be utilized to demonstrate integrated components for pumping, gas bubble 
trapping and removal, and enhanced mixing.   
Next, a three-layer PDMS with silicone membrane microfluidic platform will be 
developed to control fluid flow for nucleic acid purification processes.  This microfluidic 
chip will be capable of taking a raw biological sample through the steps of cell lysis and 
solid phase nucleic acid extraction to deliver purified DNA or RNA for testing and 
analysis.  The microfluidic chip will be mounted on a portable, desktop control system to 
allow automated device operation in clinics, laboratories, or the field.   
Finally, a disposable oscillatory flow PCR chip will be made from polycarbonate 
to amplify low concentrations of nucleic acid.  The PCR module will also be controlled 
by the same instrument used for nucleic acid extraction.  Temperature control will be 
provided by external heating blocks, and internal chip fluid temperature will be 
determined by numerical simulations.  This device will be a step towards having a 
universal nucleic acid purification device to fill the much-needed niche in sample 
preparation for lab-on-a-chip applications.  
  
TABLE OF CONTENTS 
 
 
ABSTRACT  ...................................................................................................................... iii 
 




1. INTRODUCTION .........................................................................................................1 
1.1 Motivation ..........................................................................................................2 
1.2 PDMS-Based Microfluidic Components and Fabrication Background.............6 
1.3 Microchip-Based Nucleic Acid Extraction ........................................................8 
1.3.1 Solid Phase Extraction Introduction and Background ............................8 
1.3.2 Current State of Microfluidic Nucleic Acid Sample Preparation ............9 
1.4 Nucleic Acid Amplification  ............................................................................15 
1.4.1 Microchip Based PCR ...........................................................................15 
1.4.2 Oscillatory Flow PCR  ..........................................................................16 
1.5 Project Overview  ............................................................................................20 
1.5.1 Summary  ..............................................................................................20 
1.5.2 Chapter Overviews  ...............................................................................21 
1.6 References ........................................................................................................23 
 
2. BUBBLE INCLUSION AND REMOVAL USING PDMS MEMBRANE- 
BASED GAS PERMEATION FOR APPLICATIONS IN PUMPING, 
 VALVING AND MIXING IN MICROFLUIDIC DEVICES  ....................................36 
 
2.1 Abstract ............................................................................................................37 
2.2 Introduction ......................................................................................................37 
2.3 Background ......................................................................................................38 
2.3.1 Pumping  ................................................................................................38 
2.3.2 Bubble Injection and Removal ..............................................................38 
2.3.3 Bubble Enhanced Mixing  .....................................................................40 
2.4 Materials and Methods .....................................................................................40 
2.4.1 Pumping  ................................................................................................40 
2.4.2 Bubble Injection and Removal ..............................................................41 
2.4.3 Mixing  ..................................................................................................41 
2.5 Results and Discussions  ..................................................................................42 
2.5.1 Glass Channels  .....................................................................................42 
2.5.2 Bubble Removal  ...................................................................................42 
 v 
 
2.5.3 Mixing  ..................................................................................................43 
2.6 Conclusion  ......................................................................................................44 
2.7 References  .......................................................................................................44 
 
3. NUCLEIC ACID EXTRACTION SYSTEM  .............................................................46 
 
3.1 Introduction ......................................................................................................47 
3.1.1 Extraction System Overview .................................................................47 
3.2 Materials and Methods .....................................................................................48 
3.2.1 Chip Design and Fabrication .................................................................48 
3.2.2 Solid Phase Extraction Chip Fabrication ...............................................54 
3.2.3 Nucleic Acid Quantification Methods  ..................................................57 
3.2.4 Extraction Protocols  .............................................................................60 
3.2.5 Microfluidic Control System .................................................................61 
3.2.6 Surface Modification .............................................................................63 
3.2.7 RNA Extraction .....................................................................................63 
3.2.8 DNA Extraction .....................................................................................65 
3.3 Results ..............................................................................................................65 
3.3.1 Microfluidic Chip Fabrication ...............................................................65 
3.3.2 Silicate Solid Phase Membrane Extraction Yield 
Characterization and Improvement .......................................................67 
3.3.3 Nucleic Acid Quantification Methods ...................................................70 
3.3.4 Microfluidic Control System .................................................................70 
3.3.5 Surface Modification .............................................................................70 
3.3.6 Nucleic Acid Extraction ........................................................................72 
3.4 Conclusions ......................................................................................................79 
3.5 References ........................................................................................................80 
 
4. OSCILLATORY FLOW PCR WITH EVAPORATION CONTROL ON A 
 POLYCARBONATE CHIP.........................................................................................81 
 
4.1 Abstract ............................................................................................................82 
4.2 Introduction ......................................................................................................82 
4.3 Materials and Methods .....................................................................................83 
4.3.1 Chip Fabrication ....................................................................................85 
4.3.2 Temperature Control  ............................................................................89 
4.3.3 Temperature Modeling  .........................................................................90 
4.3.4 Temperature Testing ..............................................................................96 
4.3.5 Pumping/Integration  .............................................................................97 
4.3.6 PCR Process Parameters .......................................................................97 
4.3.7 Gradient PCR  .......................................................................................98 
4.3.8 Melting analysis  ...................................................................................99 
4.3.9 Evaporation Control  .............................................................................99 
4.3.10 Chip Coating  .....................................................................................100 
4.4 Results  ...........................................................................................................101 
4.4.1Chip Fabrication ...................................................................................101 
 vi 
 
4.4.2 Numerical Simulations ........................................................................101 
4.4.3 Evaporation Control ............................................................................108 
4.4.4 Amplification .......................................................................................111 
4.5 Conclusions ....................................................................................................114 
4.6 References ......................................................................................................115 
 
5. CONCLUSIONS AND FUTURE WORK ................................................................116 
5.1 Conclusions  ...................................................................................................117 
5.2 Contributions..................................................................................................119 




A: MICROFLUIDIC SAMPLE PREPARATION: CELL LYSIS 
 AND NUCLEIC ACID PURIFICATION .................................................................124 
 
B: PROTOCOLS FOR EXTRACTION OF NUCLEIC ACID 
 USING LABVIEW CONTROLLED INSTRUMENT  ............................................138 
 
C: MATLAB CODE FOR 1D STEADY STATE AND 1D 
 TRANSIENT SIMULATIONS FOR INTERNAL TEMPERATURES OF 










1.1 Current state of reported microfluidic nucleic acid sample preparation systems ..........5 
 
3.1 Summary of protocol steps as performed by the microfluidics automated control 
program ........................................................................................................................71 
 
3.2 RNA extraction yields from four samples of E. Coli cells ..........................................75 
 
3.3 List of microfluidic extraction runs and RNA quantitation for each run .....................76 
 
3.4 Nucleic acid extracted from multiple sample types .....................................................79 
 
4.1 Description of PCR reaction chemistry .......................................................................98 
 
4.2 Simulated and calculated values for heat flux and convection coefficients based on 
chip surface temperature ............................................................................................104 
 
4.3 Calculated and measured chip surface temperatures .................................................105 
 
4.4 Effect of heat sink compound on temperature uniformity .........................................106 
 
Table 1 Design considerations for a cell lysis component ...............................................131 
 
Table 2 Comparison of nucleic acid techniques ..............................................................134 
 
B.1 Protocol steps for basic extraction of DNA ..............................................................139 
 
B.2 Protocol steps for basic extraction of RNA ...............................................................140 
 
B.3 Protocol steps for extraction of RNA from viral samples .........................................142 
 
B.4 Steps for extracting RNA from bacteria samples ......................................................145 
 














Biological assays based on nucleic acid (DNA and RNA) analysis have been 
explored for a wide range of applications: pathogen detection,1-8 genetic analysis,9-12 
environmental monitoring,13-18 terrorism or biowarfare agent detection,19, 20 foodborn 
illness prevention,21-24 and others.  In each of these cases rapid on-site detection is 
desired, but current laboratory-based nucleic acid detection methods are generally not 
compatible with this goal.  Such methods require highly trained laboratory staff, 
specialized equipment, and clean environments to reduce the risk of contaminating 
samples.  As an alternative to lab-based methods, microfluidic lab-on-a-chip devices may 
be able to deliver rapid, on-site detection and are appealing for their ability to consolidate 
the steps needed for nucleic acid analysis onto a single, compact device. 
Since its inception over two decades ago, the field of microfluidics has surged as 
people have seen the potential benefits of miniaturized systems capable of performing 
rapid biological assays.  Microfluidic systems progressing towards the goal of reducing 
complex laboratory analysis processes onto a single lab-on-a-chip device often rely on 
nucleic acids as the main analysis target because of their ubiquity, stability, and 
specificity.   Many different sensing systems have been developed using techniques such 
as melting analysis after polymerase chain reaction (PCR),25 surface plasmon resonance 
(SPR),26, 27 microarrays,28-31 and other technologies.32-36  While work in microfluidics has 
been ongoing for many years, there have been few significant advances towards 
widespread commercialization of microfluidic systems in recent years and some have 
expressed doubt about whether microfluidic devices will be able to reach this potential.  
George Whitesides, one of the leading microfluidic authorities, illustrates this issue and 
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provides potential reasons for this lack of progress in the following statement: 
[Microfluidics] offers so many advantages and so few disadvantages. . 
. . But it has not yet become widely used. Why not? . . . 
Revolutions in technology require both a broad range of different types 
of components and subsystems, and their integration into complete, 
functional systems. . . that can be used by non-experts. . . .  
The original hope for microfluidics, and that which still motivates many 
of us working in the field, is that it will be a practical technology. . . 
Above all, it must become successful commercially, rather than remain 
a field based on proof-of-concept demonstrations and academic papers. 
37 
 
This statement aptly summarizes the motivation behind the research presented in this 
work.  As supported by the above statement, the first requirement for a microfluidic 
technological revolution is an increase in the number and variety of microfluidic 
components and subsystems.  Work on new components, and their application to lab-on-
a-chip fluid handling, increases the number of tools available to researchers.  These 
components form the basic units which can be used to assemble more complex systems 
capable of performing the fluid handling tasks for on-chip assays.   
 Once sufficient components and subsystems have been identified, there remains 
the task of integrating these components into functional systems.  Primary research on 
improved microscale pumps, valves and mixers does little to expand the use of 
microfluidics if they cannot be integrated into operative systems.   Such integration needs 
to consider the compatibility of these components with each other as well as to the 
samples, chemical reagents, and control architecture.   
 The last requirement is that the integrated microfluidic system must be usable by 
nonexperts.  This need highlights a problem faced by a large number of microfluidic 
devices where the expertise and equipment required to operate the microfluidic device 
prohibit its widespread use.  Such systems have come to be known as “chip-in-a-lab” 
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devices, a critical term derived from the “lab-on-a-chip” designation, drawing attention to 
the failure of microfluidic systems to simplify laboratory processes. 
 Even with some of these unsolved challenges in microfluidics, there are several 
specific application areas that have benefited from microfluidic technologies.  An 
example of one such application is single cell analysis,38, 39 where the economies of scale 
available with microfluidics permit higher throughput with lower cost, while 
simultaneously simplifying the automation of analysis.  In this manner single cells have 
been the target for protein analysis40 and gene expression.41  Microfluidic devices have 
also been successfully used to synthesize carriers for drug delivery systems.42, 43  But 
perhaps the largest field of success in current microfluidic research and technology is 
biomolecule detection.  Microfluidic devices have the ability to isolate, amplify, or detect 
target molecules, most often DNA and RNA. 
While such techniques show great promise in expanding the role of microfluidic 
systems in reducing human intervention in performing bioassays, there is still a problem. 
These sensing platforms demand purified nucleic acids, which typically require manual 
genetic extraction and purification methods to remove unwanted background material 
from the sample.  Incomplete integrated sample preparation has thus limited the use of 
lab-on-a-chip devices to specialized laboratories with the capability to perform the 
sample preparation steps.  To achieve the widespread development of bench-top and 
portable microfluidic analysis systems with true sample-in, answer-out capabilities, 
development of highly integrated and efficient nucleic acid purification sample 
preparation devices will be needed.  
The need for sample preparation devices is especially evident in cases where 
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analysis chips neglect the important sample preparation step.  Instead, off-chip laboratory-
based nucleic acid sample preparation methods are used as preliminary steps to provide 
purified nucleic acid as the sample.  Current bench-top nucleic acid sample preparation 
techniques are highly labor intensive, requiring skilled human interaction at multiple 
junctions to perform steps such as: filtration, cell lysis, centrifugation, nucleic acid 
separation, etc.44  The incorporation of these steps into a single lab-on-a-chip device would 
yield many benefits including the elimination of the need to have highly skilled laboratory 
personnel perform the operations, a reduction in the chance of sample cross contamination, 
and the minimization of the amounts of costly reagents.    
A wide variety of researchers have been working to achieve these goals.  The 
current state of microfluidic nucleic acid sample preparation systems is summarized in 
Table 1.1, with further discussion in section 1.3.   Table 1.1 demonstrates a current lack of 
microfluidic sample preparation systems capable of starting with multiple sample types to    
Table 1.1  Current state of reported microfluidic nucleic acid sample preparation systems.  











15, 47-61      
12, 14, 62-65      
66-71      
9, 13, 72-79      
80-82      
29, 83, 84      
85, 86      
87, 88      
89-91      
92      
93-95      
96-98      
99      
Utah System      
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extract the target molecule (DNA or RNA) in an automated fashion with an optional PCR 
module for amplification.  There are a large number of devices capable of extracting 
DNA or RNA, but targeting both types of nucleic acid is less common.  Of those that can 
extract both DNA and RNA, there are even fewer that report automation, the capability of 
handling multiple sample times, or integrated PCR capability.  However, all of these 
processes are needed in a generic nucleic acid sample preparation to be fully successful 
and enable further development and commercialization of microfluidic nucleic acid 
analysis systems. Accordingly, this work introduces a system capable of filling this need 
and is a step towards solving the problems which have labeled nucleic acid sample 
preparation the weak link in microfluidic biodetection,45 and the most important obstacle 
to a revolution in biomolecule analysis.46 
1.2 PDMS-Based Microfluidic Components and  
Fabrication Background 
The adaptation of the multiple fluid handling steps of sample preparation to a lab-
on-a-chip system requires on-chip components such as pumps, microchannels, valves, 
and mixers.  There have been many reports in the literature on component improvements 
and fabrication methods for these components in substrates of glass,100-102 silicon,47, 103 
and polymers.104-106   
One method for fabricating microfluidic chips evolved from integrated circuit 
(IC) silicon micromachining. This technique creates microchannels and functional 
microfluidic components using microfabrication processes such as photolithography, wet 
or reactive ion etching, chemical vapor deposition, and others.  Devices created in this 
manner exhibit complexity and versatility in performing microfluidic fluid handling 
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operations.  Another benefit derives from the ability to seamlessly integrate control 
circuitry on the same chip using IC fabrication protocols.  However, production 
complexity and cost are deterrents for silicon microfluidic chips to find widespread use as 
disposable medical diagnostic devices.  In addition, microfluidic devices tend to be 
relatively large, compared to typical silicon structures, so silicon processing technologies 
tend to be expensive and over-capable when considered for microfluidic technologies. 
Polymers have emerged as alternative substrates to silicon-based microfluidics 
with the promise of providing inexpensive disposable chips.  Fabrication of these devices 
is accomplished using injection molding, hot embossing, layered stacks and casting.  
Active components are difficult to achieve with polymers, so these chips usually rely on 
external actuators and pumps to perform on-chip operations.   
One polymer of note that finds extensive use in the microfluidic community is 
polydimethyl siloxane (PDMS), a silicone-based flexible elastomer that has desirable 
chemical properties and can be rapidly molded around structures to create sub-
micrometer features.  Publications reporting the use of replica molding of PDMS as a 
substrate for microfluidic applications began to appear in the late 1990s.107-109  An 
increase in the popularity of PDMS was precipitated by several landmark papers:  PDMS 
as a microfluidic substrate and a rapid prototyping process introduced by the George 
Whitesides group,110, 111 and monolithic valves and large scale integration by the Stephen 
Quake group.106, 112 Advancements in PDMS-based components and integration have 
continued with new valve designs101, 113 and pumping schemes,114 allowing other 
researchers to create more complex microfluidic platforms.115  Further study of the 
capabilities of PDMS as a microfluidic substrate will help in the development of devices 
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with the capabilities to handle the complex fluid handling for nucleic acid extraction. 
1.3 Microchip-Based Nucleic Acid Extraction 
1.3.1 Solid Phase Extraction Introduction and Background 
In order to use nucleic acids as target molecules for bioanalysis, the nucleic acid 
first needs to be released from the cells, isolated, and purified by purging unwanted 
cellular debris.  While there are other means (e.g., phenol-chloroform based precipitation, 
isotachophoresis) for completing this extraction process, a large portion of the recent 
methods for both bench-top and microfluidic extraction have relied on the principle of 
solid phase extraction.  Solid phase extraction relies on three main steps: binding, 
washing, and elution. In the binding step, nucleic acid is bound to the surface of a solid 
phase under certain buffer conditions.  For washing, cellular debris and unwanted 
contaminants are rinsed off of the solid phase while the nucleic acid remains attached.  
Finally, the nucleic acid is eluted from the solid phase with a low ionic strength elution 
buffer. 
One of the first demonstrations of solid phase extraction was performed in 1979 
by Vogelstein and Gillespie and used a glass surface as the solid phase to extract DNA. 
Vogelstein and Gillespie  used a chaotropic salt solution to selectively bind DNA to glass 
surfaces (in powdered form) to elute the DNA molecules from the surrounding agarose 
separation medium.116  Under the conditions reported, they found that 1 μg of DNA 
would bind to a glass surface of about 750 mm2.  To increase the surface area, they 
employed a glass that had been ground to powder.  Glass fiber filters were also used, but 
they found that recovery was too small to quantify.  In their experiment, over 99% of the 
DNA was bound to the glass, with a recovery of about 90%.  It should be noted that they 
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were using prepurified DNA that had previously been separated in agarose gel, and their 
DNA extraction was simply a separation from agarose, not from original cellular 
material. 
This method was expanded upon in 1990 by Boom et al.117  They demonstrated 
that a similar procedure could be used to purify nucleic acids (both DNA and RNA) from 
cell-rich samples similar to clinical samples.  In their process, they introduced the use of 
two new chaotropic salt solutions to act as the binding buffer.  Guanadinium thiocyanate 
(GuSCN) and guanadinium hydrochloride (GuCHl) proved to be powerful tools for the 
purification of nucleic acids because they have the ability to lyse target cells and 
subsequently bind the released nucleic acid to the solid particles.  GuSCN also has the 
beneficial property of deactivating nucleases, making it especially useful in purifying 
more fragile RNA molecules.  Nucleic acid extraction from human urine and serum was 
shown to have over 50% efficiency using their method, despite evidence that nucleic acid 
was being lost at each major step of the extraction process. 
Baker et al. used glass fiber filters to extract pure DNA from whole blood, but 
their process does not depend on chemical buffers to promote reversible DNA adhesion 
to the glass solid phase.118  Instead, white blood cells are trapped in the filter matrix and 
lysed using a detergent solution.  The DNA is then also physically trapped in the filter 
until released in a special incubation vessel and eluted.  This process demonstrates the 
ability of glass filters to be used to purify DNA, but does not explore using the filters as 
the binding surface using solid phase extraction techniques with chaotropic salts.   
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1.3.2 Current State of Microfluidic Nucleic Acid Sample Preparation 
The NA purification processes described thus far involve several steps requiring 
manual manipulation by personnel.  Commercial systems often used in laboratories today 
use variations on this process. These and other similar methods require pipetting, mixing, 
centrifuging, vortexing, transferring containers, incubation and other time consuming and 
labor intensive steps.  Labor reduction has been achieved by the implementation of 
robotics to complete the fluid handling steps, but such systems are too expensive to see 
much use outside of centralized laboratories.  Microfluidic chip analysis methods lend 
themselves well to such situations by reducing the required human involvement by 
integrating the essential steps onto small benchtop platforms.  The literature shows that 
nucleic acid extraction is a process that has been adapted in several variations to 
microfluidic chips. 
Performing nucleic acid extraction on-chip has been the focus of much attention 
in the literature.  Appendix A is a published literature review of microfluidic 
advancements in on-chip cell lysis and nucleic acid purification.  An updated review 
including emphasis on devices related to the system presented in this work is discussed in 
the remainder of this chapter.  
The stability and specificity of DNA, as compared to RNA, has made it an 
attractive option as the target for microfluidic based bioassays, leading to a large number 
of on-chip DNA extraction devices.15, 47-61 A few of the most recent and most powerful 
will be discussed. 
The research group of James P. Landers has published extensively on methods of 
performing solid phase based nucleic acid extraction on microchips.  In 2003 Wolfe et 
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al.61 introduced the idea of using a sol-gel to immobilize silica beads inside microfluidic 
channels to form a porous, high-surface area solid phase on which nucleic acids can bind.  
This method eliminated the difficulties of including a weir to hold the beads in place. A 
guanidine-based binding solution with DNA was passed through the porous matrix, 
washed with ethanol, and eluted with TE buffer.  This process generated extraction 
efficiencies ranging from 8.7% to 70.6%. 
Breadmore et al. expanded on this work by using biological samples, including 
whole blood and bacteria.95 Extraction efficiency data were not presented, but the 
effectiveness of extraction was qualitatively demonstrated by amplifying the extraction 
product by PCR and performing gel electrophoresis.  As with their previous work, no 
mention was made on how pumping and interfacing with samples and reagents were 
done.  Similar results were later obtained by the same group80, 81 with the distinction that 
the solid phase was fabricated as a porous monolith instead of immobilized beads.  Other 
research groups have reported similar results using an amino silica monolith.55 
One final method of note introduced by the Landers group deviates from their 
common practice of using guanidine-based buffers to bind nucleic acid to silica surfaces.  
Instead, Hagan et al.91 coat the silica surface of glass microchannels with chitosan.  The 
nucleic acid can then be bound to and eluted from the chitosan using buffers at different 
pH that create induced-charge electrostatic means.  Using this method, a slight 
improvement in extraction efficiency was observed (65% vs 40% for chitosan vs plain 
silica, respectively), and reagents that can inhibit later PCR amplification reactions were 
avoided.   
Other efforts to perform nucleic acid purification on the microscale include using 
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optimized microfabricated silica pillar structures as the solid phase to extract DNA from 
E. Coli bacteria.47  Mesoporous silica was used to demonstrate that pore sizes of 2-5nm 
were effective at binding duplex DNA without needing high ionic strength chaotropic salt 
solutions.119 Similarly, DNA was extracted on a nanoporous aluminum oxide membrane 
with NaCl acting as the binding promoter.53, 120   Xing et al. fabricated a porous silicon 
dioxide matrix on a silicon chip to serve as the solid phase.121 
In a step towards more disposable chips, Bhattacharyya and Klapperich presented 
a thermoplastic microfluidic chip for nucleic acid purification fabricated by hot 
embossing.3, 49  To create the solid phase, a porous plastic monolith was impregnated 
with silica particles.  Successful purification of RNA and DNA was demonstrated.  
Another plastic-based chip used layered double hydroxides (LDH) on the surface of 
polycarbonate chips to bind DNA, which was released in a slight acid etch of the LDH.52  
Yet another approach to solid phase extraction employs a lab-on-valve system 
with a renewable silica microcolumn packed inside a channel.51 A finding of note from 
this setup is that longer residence times of the target in proximity with the silica surface 
increase the elution efficiency.  Nanassy et al. also avoided microchip extraction by 
extracting DNA directly onto glass microscope slides.50   
A highly parallel system was shown by Park et al. where a polycarbonate 96-well 
microfabricated titration plate was used to extract DNA from bacteria using a NaCl 
immobilization buffer, ethanol wash and DI water elution.122  
The works discussed above are very valuable at exploring the methods and 
effectiveness of microchip-based solid phase extraction of nucleic acids.  However, little 
effort has been made in the publications discussed to address the interface between the 
13 
microchip and the outside world.  Expensive and complicated fluid pumping and analysis 
apparati are required to run such microchips, demanding the same kind of technical 
expertise required with current benchtop protocols.  To make a practical difference, 
microfluidic extraction systems need to be highly integrated and automated, as well as 
effective. 
One more integrated system was reported in 2007, which used a silicon/glass 
microfabricated chip as the heart of the extraction process.69, 123, 124  The chip included a 
size-based exclusion filter to remove red blood cells in order to extract DNA and viral 
RNA from blood samples.  The integrated system was shown to be effective by 
performing PCR and RT-PCR on DNA and RNA samples, respectively, but separate, 
portable systems had to be made for the DNA and RNA protocols. 
Beier et al. devised a sample preparation chip with integrated components such as 
inlet, filter, solid phase extraction chamber, reagent storage, valves, etc.87  The chip is 
operated by an instrument, eliminating the need for other external equipment.  While this 
device demonstrates hands-free automation of sample preparation, the target application 
is very specific: extracting viral RNA from cervical liquid for the detection of HPV 
infections.  
Another popular method of performing solid phase extraction is to use silica 
superparamagnetic particles, which allows the mobile solid phase to be manipulated 
using magnetic fields.  One device uses these particles, immobilized by permanent 
magnets, to purify DNA from blood and perform PCR.12, 125  Commercial extraction 
magnetic bead systems have also been used in conjunction with microfluidic systems to 
combine sample preparation and hybridization for microarrays.28 
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Chen et al. presented a disposable polycarbonate cassette that contains reagents, a 
silica membrane modified from a commercial extraction kit, and a PCR chamber.97  The 
temperature of the stationary PCR reaction chamber is controlled using thermoelectric 
units at a rate of approximately 5˚C/sec.  While their work is impressive in providing a 
self-contained chip that performs extraction, PCR, and RT-PCR for RNA and DNA 
detection, the types of samples used were limited to spiked saliva samples. No efforts 
were reported to extract nucleic acids from blood or other more complex matrices. 
Another fully integrated sample preparation chip was demonstrated by Ritzi-
Lehnert et al. with application towards analysis of respiratory viruses from nasal swabs.96  
They present a lab-on-a-chip nucleic acid purification and amplification system focused 
on viral RNA detection based on the one-tube RT-PCR QIAplex method.  The on-chip 
RT-PCR and PCR thermal cycling is achieved using rotating constant temperature 
clamps on the top and bottom of the PCR reaction chamber with ramp rates of 
approximately 5˚C/sec for large volume (120 μl) PCR reactions.  While this device 
demonstrates the ability to extract both RNA (target) and DNA (control), the sample 
preparation method is explicitly assay specific for RNA respiratory viral detection and no 
effort was reported to expand the types of sample inputs to create a more universal 
sample preparation device. 
Previously reported work from Bruce Gale’s lab at the University of Utah has 
produced a microfluidic chip for extraction of RNA and DNA from blood and bacteria 
samples as a step towards universal sample preparation.99  However, this device required 
several off-chip lysis steps that are specific to the target cell prior to loading in the chip.   
Also, no attempt has been made to integrate PCR control into the automated extraction 
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process.  The current system is an improvement in that it integrates cell lysis on-chip and 
a PCR module for nucleic acid amplification.   
1.4 Nucleic Acid Amplification 
Using microfluidics to perform nucleic acid extraction and analysis presents a 
barrier in that only small amounts of sample are used, which makes the detection of 
scarce target molecules especially difficult because there can be very low concentrations 
of the target available.  Using polymerase chain reaction (PCR) to amplify the number of 
molecules available for analysis shows great promise in overcoming this difficulty. PCR 
makes copies of targeted DNA strands by using enzymatic primers to locate and replicate 
specific nucleotide sequences.  The process depends on having the primers go through a 
temperature cycle where the DNA molecule denatures (unzips the double-strand into two 
single strands) at a high temperature, anneals (the primers attach to the specific sequence 
of interest) at a low temperature, and extends (the primer moves along the strand, 
inserting complementary base pairs to again create a double-stranded DNA molecule) at a 
moderate temperature.  Thus, the amount of target DNA can be doubled simply by 
putting the prepared sample through a single temperature cycle.  
 
1.4.1 Microchip Based PCR  
Adapting PCR to the microchip has seen much attention because of the rapid 
thermal cycling possibilities when using small liquid volumes, the reduced reagent usage, 
and the ability to reduce contamination between processing steps.  There are several 
substrates that have been used in the manufacture of microfluidic PCR systems. The most 
prolific substrates are silicon,2, 126-137 glass11, 138-150 or a silicon/glass hybrid.83, 151-156   
These substrates are attractive as they take advantage of well-established micromachining 
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practices and allow easy integration with optical and electrical components. Polymers 
have seen accelerated interest as substrates for PCR chips as the less expensive 
manufacturing processes enhance the possibility of making the chips disposable. Polymer 
substrates used include PDMS,73, 157-163 polycarbonate,75, 98, 164-168 or other plastics.169-173  
1.4.2 Oscillatory Flow PCR 
While there are a wide range of techniques that can be applied to performing 
PCR, oscillatory-flow PCR is of particular interest and will be used extensively in this 
dissertation.  Oscillatory flow PCR operates on the principle of pumping the sample fluid 
through distinct zones held at the required cycle temperature.  With this system 
architecture, the plug of fluid moving to the new temperature zones is the only 
component in the device that undergoes temperature transitions, thus eliminating the need 
to unnecessarily heat and cool the chip itself.  Oscillatory flow PCR has the added 
advantage over continuous flow PCR devices due to its flexibility in cycle times and 
temperatures.  Specifically, many PCR protocols require a long incubation period at a set 
temperature for initialization or finalization of the PCR process. This incubation period is 
especially evident when dealing with RNA, which requires an initial reverse transcription 
step to convert the RNA strand to a more stable complementary DNA strand before PCR 
operation.  These advantages make an oscillatory flow PCR chip advantageous as a 
module for a sample preparation device that deals with both DNA and RNA. 
Such an oscillatory PCR device was presented by Bu et al. to provide the 
flexibility in thermal cycling control with the thermal advantages of flow based PCR.174  
They presented a microfabricated silicon chip with integrated heaters, a peristaltic pump, 
and optical sensors to detect fluid droplet position.  However, the expensive, complex 
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fabrication methods make this chip a poor candidate for widespread use as a disposable 
chip. 
Hardt et al. and Muchow et al. presented polymer chips (PMMA and cyclo olefin 
copolymer) that rest on three heater blocks with embedded heater cartridges.175, 176  A 
pneumatically coupled ferrofluid pump was used as the actuation chamber for droplet 
pumping.  Fluid droplet temperatures were predicted by CFD simulations based on 
temperature settings and infrared measurements.  Evaporation was observed, but no 
attempt at evaporation control was reported.  
Auroux et al. presented the first results obtained by oscillatory flow PCR.177 
Previous to their efforts, oscillatory flow PCR as a technology was theoretical or 
computational in nature.  Channels were formed using patterned SU-8 on PMMA 
substrates.  Pumping was done by an external syringe pump.  The flexibility of the 
oscillatory flow PCR concepts was demonstrated by running several PCR programs with 
modifications to the fluid residence times.  The nonoptimized system demonstrated 
amplification, although at a significantly reduced efficiency (25%) compared to 
commercial systems. 
A radial temperature gradient oscillatory PCR geometry was presented by Cheng 
et al. where a PMMA fluid chip was placed in contact with a circular ITO/glass heater 
substrate.178  They also attempted to mitigate evaporation loss by increasing the pressure 
in the channel as the fluid was pumped over the high temperature zone, which was 
accomplished by having the high temperature zone near the termination of a dead-end 
channel causing the air in the channel to be pressurized as the fluid approaches, thus 
raising the vapor pressure.  Using this method, they reported 30% evaporation after 30 
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cycles.  However, the high pressures produced by this method require pumping by an 
external syringe pump. 
Another silicon-based microfluidic chip reported by Wang et al. demonstrated 
amplification of a human papilloma virus target sequence after 35 cycles in 15 
minutes.179    While this chip demonstrated good amplification, faster than conventional 
instruments, it suffered from a high degree of fabrication complexity that will make it 
difficult to be integrated as a disposable component. 
Ohashi et al. performed PCR in a droplet-in-oil system where sliding permanent 
magnets were used to move magnetic particles containing PCR droplets across a 
temperature gradient.166 
Another paradigm for oscillatory PCR is based in digital microfluidics as 
presented by Sista et al.1 In this system, fluid droplets are moved by electrowetting 
manipulation.  Their device performs PCR on a printed circuit board substrate by 
shuttling a droplet back and forth between two temperature zones heated by aluminum 
heater bars.  While providing flexibility, this chip requires high voltages for 
electrowetting and laborious glass drilling and bonding processes. 
Sciancalepore et al. cast a capillary tube in PDMS and positioned the tube over 
three patterned microheaters.180  A droplet of PCR reagents was suspended in an oil 
phase and pumped by syringe pumps over the temperature zones.  A nested PCR cycle is 
achieved four times faster (50 min) than with conventional systems.  A later report 
showed the capability of this design to greatly reduce evaporation of the fluid droplet 
during the PCR process.181  Drawbacks to this design include a 4 ˚C temperature 
variation in the temperature zones and a slightly slower thermal response time due to 
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interference from layers of glass and PDMS.  
Sugumar et al. developed a glass chip with serpentine channels that pass over 
three temperature zones for the amplification of salmonella DNA.182  While their use of 
oil, a sealed channel and elevated pressure kept evaporation to about 10% (lower than the 
rate seen in other polymer chips up to this point in this discussion), the difficulty in 
fabricating glass channels and bonding glass substrates makes polymers a more attractive 
option for disposable chips. 
Zhang et al. presented a multichannel oscillatory flow PCR device with 
applications in detecting food-borne pathogens.  PCR was carried out in PTFE capillary 
tubes which were set into small channels cut into copper blocks. A glass cover was then 
bound over the top of the channels.183  Temperature zones were heated by cartridge 
heaters set into the copper blocks; pumping was done by an external syringe pump; and 
the temperature was controlled by a computer interface and monitored by a thermocouple 
embedded in the copper.   Successful multiplexed amplification of food-borne pathogens 
from bacteria was demonstrated.  Evaporation control was achieved using oil plugs on 
either side of the sample plug. 
Mechanical pumping of a PCR fluid droplet between temperature zones on a 
PDMS/glass hybrid chip was demonstrated by Chia et al.184  The electromagnetic coil 
actuator depresses a plastic flake into the PDMS chamber, forcing the fluid out into a 
different temperature zone.  While they reported the time it takes heat up the temperature 
zones, there was no discussion of the time required for the fluid to heat and cool when 
pumped to different zones.  Also, no discussion of evaporation rates was included. 
The above discussion of the state of the art in microfluidic sample preparation 
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systems shows the need for a device like the Utah system, capable of performing 
automated extraction of both DNA and RNA.  PDMS has proven a viable substrate for 
microfluidic devices, but further expansion of component capabilities will lead to more 
complex devices.  Solid phase extraction has been successfully applied to microfluidic 
devices, but further work is needed to demonstrate automated systems with enough 
protocol adaptability to handle different sample types and target molecules.   Microfluidic 
PCR devices are effective at rapidly amplifying nucleic acids.  The oscillatory flow PCR 
chips provide flexibility in temperature, cycle number, and residence times with 
accompanying rapid cycles.  An oscillatory flow PCR device on a plastic substrate that 
can control evaporation will be a step forward in disposable PCR chips integrated with 
extraction systems. 
1.5 Project Overview 
1.5.1 Summary 
The research presented here is a step towards the realization of the goal to have 
functional microfluidic systems that can be operated by nonexperts by implementing 
practical solutions to problems that have hindered widespread adoption of microfluidic 
systems.  Specifically, this work focuses on the generation of a nucleic acid sample 
preparation system for the purification of nucleic acid from biological samples of blood, 
bacteria cells, and cultured virus samples. This system incorporates on-chip chemical 
lysis of blood and bacteria cells and extracts purified DNA or RNA using solid phase 
extraction techniques. The system incorporates automated control of all process steps, so 
users need only load the sample.   A polymerase chain reaction (PCR) module is also 
incorporated to allow amplification of target nucleic acids to increase assay sensitivity. 
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1.5.2 Chapter Overviews 
Chapter 2 of this work presents findings on how PDMS membranes can be 
incorporated into microfluidic devices to perform essential fluid handling tasks.  
Specifically, the chapter outlines how the gas permeability of PDMS membranes is 
turned from a weakness to a strength to perform controlled pumping at low flow rates, 
reduce air bubble interference, and enhance mixing.  These component advancements 
were instrumental in proving the versatility of three-layer PDMS chips at fluid handling 
tasks.  Consequently, a three-layer PDMS chip platform was chosen for development of 
the main fluid control chip for the nucleic acid sample preparation platform. 
Fabrication methods and microfluidic components are explored that will aid in 
reducing the complexity of device fabrication, making a final microfluidic system 
feasible.  A thin PDMS membrane will be included into microfluidic devices to perform 
pumping, valving, bubble removal, and mixing tasks.  All of these components will be 
fabricated using a simple three-layer technique, where a thin membrane is bonded 
between two thicker substrates (PDMS or glass) that house the fluid channels and 
packaging/control mechanisms. Having such a simple fabrication method with the ability 
to control many fluid-handling tasks can help reduce the complexity of manufacturing 
microfluidic platforms and minimize the number of external controls required for a lab-
on-a-chip device.   
In Chapter 3 a masked corona discharge bonding method185 will be explored to 
improve pumping and valving for the more complex fluid handling applications that will 
be required based on the choice of cell lysis and extraction methods.  Chemical cell lysis 
and subsequent solid phase extraction of nucleic acids require a complex sequence of 
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reagent mixing to efficiently recover the nucleic acid.   
A major focus of Chapter 3 is on the generation of a single PDMS microfluidic 
chip with the capacity to control all needed fluid handling tasks for nucleic acid 
extraction.  A range of possible extraction protocols will be considered in the design in 
order to make the device applicable to multiple situations.  The chip will be able to draw 
from a bank of reagents to perform different extraction protocols.  The system will be 
automated, controlled by a programmable LabView interface.  Different extraction 
sequence programs will be run to selectively purify DNA or RNA from different samples.  
Following extraction, the purified nucleic acid samples will be delivered to several 
different detection platforms to verify that the device adequately interfaces between raw 
sample and genetic analysis.  Specifically, DNA will be extracted and quantified using 
fluorescence, spectroscopic absorption, and PCR.  RNA will similarly be extracted and 
analyzed with fluorescence and RT-PCR with applications for viral detection. 
Advances in this field will facilitate an increase in the spread and scope of nucleic 
acid analysis, leading to more insight and discovery of underlying biological phenomena. 
The proposed work intends to generate these insights by increasing the ability of next 
generation analysis systems to rapidly process multiple samples using microfludic-based 
extraction systems.   
The work presented in Chapter 4 demonstrates a chip that couples the flexibility 
of oscillatory flow PCR in a disposable polymer chip with good temperature uniformity 
and low evaporation.   A thin multilayer polycarbonate chip will be fabricated from 
laminates.  The chip will contact an external heater block module with PID temperature 
controllers to create fixed temperature zones on the PCR chip.  Extra chip layers that 
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surround the fluid channel with pressurized water will provide evaporation control at the 
high temperatures experienced during PCR. Numerical simulations will be used to 
determine internal chip temperatures and required residence times of the fluid droplet at 
the temperature zones.  Rapid on-chip PCR will be demonstrated controlled by a 
pumping module controlled by the same instrument that performs the nucleic acid 
extraction discussed in Chapter 3.  
In total, these advancements in microfluidic sample preparation technology 
combine to demonstrate a system that improves on current reported devices by 
performing the complex fluid handling required to extract DNA and RNA from different 
sample types with an integrated PCR module for amplification. 
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Bioassays for detection or quantification of organisms often rely on nucleic acid 
detection.  The varied conditions of the sources of target genetic material (i.e., 
prokaryotic or eukaryotic cells in blood, water, stool, soil, and others) and the stringent 
purity requirements of analysis techniques most often force system-specific sample 
preparation operations, which often require time consuming and expensive manual 
handling.1  Self-contained lab-on-a-chip systems capable of preparing genetic material 
out of raw biological samples have been achieved with varying levels of success as 
presented in Chapter 1. The benefits envisioned by making nucleic acid analysis more 
readily available will be closer to realization when steps are taken towards universal 
sample preparation with the ability to take samples from various sources (blood, bacteria 
cultures, and virus samples) and selectively extract and purify nucleic acids (DNA or 
RNA). 
3.1.1 Extraction System Overview 
 
In the work described in this chapter, efforts to build and test a system for 
automated NA purification from a variety of biological samples are described.  The 
nucleic acid is purified using an integrated microfluidic fluid handling chip and a solid-
phase extraction chip.  The overall extraction process operates by pumping the sample 
and various reagents using integrated metering/mixing reservoirs through an extraction 
filter on the extraction chip where the nucleic acid is selectively bound and released 
depending on buffer conditions.  Altering the amounts, types, and sequences of reagents 
allows selective adjustment of the protocol to handle different sample types and control 
the output as DNA or RNA. These adjustments are easily accomplished by modifying a 
48 
control program and input reagents. 
This chapter is composed of several sections that report on the development of the 
microfluidic NA extraction system. First, the design and fabrication of the individual 
components are discussed. Details are provided of the fabrication of a three-layer 
polydimethylsiloxane (PDMS) microfluidic chip designed to perform the main fluid 
handling tasks.  A multilayer mold and rapid prototyping technique is employed in the 
fabrication of integrated microchannels, valves, and metering diaphragm pumps.  Second, 
a separate module is fabricated to incorporate the silica membrane used as the disposable 
solid phase for nucleic acid extraction. Calculations and experiments are performed to 
develop the filter chip architecture.  The nucleic acid extraction efficiency of the solid 
phase filters are characterized with respect to parameters such as flow rate and filter 
material.  Third, the ability of the system to handle different sample inputs is 
demonstrated by extracting DNA from both a stock DNA solution and whole blood, and 
by recovering RNA form known RNA solution standard, living E. Coli cells, and FMDV 
virus cultures.  Following extraction, the purified genetic material can be mixed with 
other reagents required for analysis techniques such as electrochemical detection or 
transfer to a PCR module as will be discussed in Chapter 4.  
3.2 Materials and Methods 
 
3.2.1 Chip Design and Fabrication 
 
3.2.1.1. PDMS chip overview 
 The heart of the NA extraction system is a microfluidic fluid handling chip 
fabricated using a three-layer approach with a fluid layer, a flexible membrane, and a 
pneumatic control layer see Figure 3.1.  The pneumatic layer forces membrane actuation  
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Figure 3.1: Diagram of 3-layer microfluidic chip. 
to operate the embedded pumps and valves. The chip design incorporates eight fixed-
volume, on-chip metering diaphragm pumps similar to those reported by Grover et al.2  
These pumps interface with 17 fluid inlet ports and two module access ports to facilitate 
adaptable protocols for nucleic acid extraction. Different pump volumes allow a range of 
input volumes to accommodate the mixing ratios of extraction protocols. 
Figure 3.2 is a schematic of where the valves and pumps are located on the chip 
layout.  Locations of other features important to chip function are also indicated.  
3.2.1.2 Valve design and operation 
 
 On-chip valves operate by applying pressure to the control layer which pushes the 
membrane against the valve seat, sealing the channel. Vacuum applied to the control 
channel pulls the membrane away from the valve seat, and fluid is then free to flow 











Figure 3.2. Diagram of functional features incorporated onto PDMS extraction chip.  
Numerically labeled features are on-chip valves, with numbers indicating the associated 
off-chip solenoid valve.  Features A-J are the metering pumps and mixing chambers,  K-
M are sample and reagent input ports, N is the waste output, O highlights postextraction 
processing section, P indicates extraction process output and external module connection, 
Q is the location of the solid phase chip, and P is the direct pressure line for drying and 




Figure 3.3: Diagram of on-chip valve and metering pump operation. A) chip with 
membrane at equilibrium.  B) Pressure applied to the Pump, P and valves V1 and V2.  C) 
Vacuum applied to V2 and P2 opens a channel for fluid to enter the inlet port and fill the 
pump reservoir. D) V2 is closed with pressure, and V1 is opened with Vacuum.  E) Fluid 
in the reservoir is forced out through the channel passing V1. 
 
On-chip valves are actuated by switching the control layer portion of the valve between 
pressure and vacuum using an off-chip electrically actuated three-way solenoid valve.   
 The valve design has the channel opening into a circular area with a gap in the 
middle.  The widened circle increases the area exposed to the pressure difference and 
reduces the pressure required to overcome the innate stiction of the membrane to the 
valve seat.  The control channel side of the valve is made a slightly larger circle than in 
the fluid channel side to reduce alignment tolerance requirements to produce a high yield 
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of operational valves over the large are of the PDMS chip.   
3.2.1.3 Pumps 
 Metering diaphragm pumps pull fluid into the chip through the access ports.  In 
the default state of the pump, control pressure pushes the flexible membrane against the 
top of the fluid reservoir, reducing the volume in the fluid side of the reservoir to the 
space around the sharp corners where the membrane cannot extend.  When vacuum is 
then applied to the control layer, the membrane is pulled to the bottom of the reservoir, 
and fluid is drawn in to fill the evacuated space.  The fluid is forced out of the reservoir 
pump by again applying pressure to the control layer, forcing the membrane up and 
displacing the fluid which exits through an open channel. The fluid layer and the 
pneumatic control layer are created by casting PDMS (Slygard 184, Dow Corning).  
Molds are made using a xurographic technique3 with features being cut from a vinyl tape 
(Instachange, 3M, St. Paul, MN) on a knife-plotter (Graphtec, Irvine CA).  After the 
features were cut in the vinyl tape, they were transferred to a PMMA substrate. This rapid 
prototyping fabrication technique allows the formation of molds with fluid channel 
widths as low as 200 μm, without the need for conventional microfabrication or 
micromachining methods, in as little as 10 minutes.  
This fabrication method was also improved for the fabrication of the fluid 
handling chip by including larger mesoscale 3D structures to interface with a range of 
larger fluid volumes (50-1000 μl) required for the extraction process. The pneumatic 
control layer mold was designed with features of different heights to increase diaphragm 
pump volumes and improve valve performance.  Different mold heights for valve 
controls were achieved by stacking cut tape layers.  Large reservoirs for the on-chip fixed 
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volume diaphragm pumps were made by bonding laser-cut PMMA features to the 
corresponding tape features using a cyanoacrylate adhesive (421, Loctite, Westlake, OH). 
 Following mold fabrication, PDMS was mixed at a ratio of 10:1 with curing 
agent, degassed in a vacuum chamber for 15 minutes, and poured into the molds.  The 
filled molds were cured in a 60 ˚C oven until fully cured (more than 2 hours).  The cured 
fluid and pneumatic control layers were removed from the molds, and pneumatic and 
fluid connection ports were cored using a 1.5 mm diameter biopsy punch (Uni-Punch, 
Clear Lake, WI).  The fluid and control layer were aligned optically under the microscope 
prior to any bonding operations and four alignment holes were cored through the PDMS 
to allow alignment of the two layers through the opaque membrane. 
A thin silicone sheet (Bisco HT-6135, Stockwell Elastomerics, Philadelphia, PA) 
was used for the membrane layer. The membrane was first bonded to the pneumatic 
control layer using plasma treatment bonding which operates by creating hydrophilic, 
chemically active functional groups on the PDMS surface that bind to other activated 
groups on the mating surface.4  The areas to be bonded on the membrane and control 
layer were exposed to the discharge from an air plasma surface treater (Enercon 
Industries, Menomonee Falls, WI) so that all surfaces were exposed for approximately 1 
minute with the treater head approximately 0.5 inches above the surface.  The treated 
surfaces were then brought into contact and pressed together with a rubber roller.  The 
control layer/membrane assembly was then incubated for 20 minutes at 60 ˚C.   
Following the first bonding step, holes were cored through the membrane to open 
the alignment holes and to produce three cross-membrane vias. One provides the port 
through which pressurized air can directly enter the chip for drying steps or to aid in 
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emptying channels.  The other two vias route the waste channel to the other side of the 
membrane in order to cross another channel without interference. 
When bonding the fluid layer to the membrane/pneumatic control layer assembly, 
steps were taken to prevent unwanted bonding at the valve seat and over the large surface 
areas of the metering diaphragm pumps.  Covering the PDMS layer to be bonded with a 
masking material during corona discharge treatment blocks areas from exposure to the 
corona plasma so that only desired surfaces are activated, as shown in Figure 3.4.  
Several masking materials were shown to be effective: rubylith electrostatic film, 3M 
Instachange tape, mineral oil, and liquid spin-on glass.  Subsequent removal of the mask 
and contact with another activated PDMS surface is shown to produce selective bonding, 
with the masked areas remaining unbound.   3M Instachange tape was used as the mask 
for this device with the mask shapes cut on the knife plotter.  Masks were manually 
placed over the areas that were not to be bonded.  Again the surfaces were treated with air 
plasma for approximately 1 minute.  Following treatment, the mask material is removed 
and alignment pins are placed through the alignment holes.  The two layers to be bonded 
are then brought into contact, compressed, and incubated as described above. 
3.2.2 Solid Phase Extraction Chip Fabrication 
The purification of target nucleic acid from background compounds that would 
impede analysis is performed using solid phase extraction techniques with a silicate 
substrate acting as the solid phase.  For nucleic acid purification on a microfluidic chip, 
the solid phase needs to be easy to integrate into the flow control structure of the chip and 
be disposable to avoid cross-contamination between extraction assays.  





Figure 3.4. Masked plasma bonding process.  The PDMS face is covered with a mask that 
exposes the surfaces to be bonded.  The surface is then activated by exposing it to corona 
discharge.  The mask is removed and the surface is brought into contact with another 
activated PDMS surface.  Areas where two activated surfaces contact are irreversibly 
bonded, while other areas remain nonbonded, even if they are in direct contact. 
 
PDMS casing enclosing a stack of silica beads (Sigma-Aldrich Corp. St. Louis, MO).  
 The PDMS casing is molded in four layers, each layer bonded to the others using 
a plasma surface treatment activation method.  The beads are held in the solid phase 
chamber between two glass microfiber filters (GF/D, Whatman, Maidstone, Kent, UK) at 
the inlet and outlet of the solid phase module.   
The next generation of silica chips omitted the beads in favor of silicate filter 
membranes only because of fabrication difficulty and the calculation that the microfiber 
filter material had approximately an order of magnitude more surface area per volume 
than the beads (5.6 x 104 vs 8.8 x 103  m2/m3).   
Disposable filter chips shown in Figure 3.5 were fabricated by sandwiching the 
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Figure 3.5. Diagram of the construction of the glass filter solid phase chip. 
 
filter material between two laser-cut PMMA blocks.  A CO2 laser (Universal Laser 
Systems) was used to cut the access ports, filter pocket, and microchannel in the PMMA 
blocks.  The filter pocket was created by laser etching a well into the PMMA with a 
shallower ring around the lip which serves to seal off the edges and force the fluid to pass 
through the filter.  The two halves of the block are sealed together using a double-sided 
pressure sensitive adhesive (467 MP, 3M).  Tubing connections are made by inserting 22 
gauge stainless steel tubing into the access ports and bonding using a UV cure adhesive 
(3106, Loctite, Westlake, OH). These connectors are press-fit into access ports located on 
the PDMS fluidic control chip. 
3.2.2.1 Filter material 
 
 Two types of glass filters were used as the solid phase membrane: borosilicate 
glass and quartz (GF/D and QM/A, respectively).  To test the extraction efficiency of the 
different filter materials, 100 ng and 200 ng samples of prepurified human genomic DNA 
were added to a chaotropic salt buffer (Qiagen, Venlo, Netherlands) and passed through 
the filters at 100 μl/min. The filters were then rinsed with 80% ethanol and dried for 2 
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minutes with pressurized air at 10 psi.  Finally, the DNA is eluted from the filters with 
100 μl of purified water.  The collected DNA was quantified using the fluorescence 
method described in later sections. 
3.2.2.2 Flow rates 
 To determine the effect of flow rate on the extraction efficiency of the NA 
extraction chip, a syringe pump was loaded with a known concentration of DNA sample 
in a binding buffer.  The syringe was connected to the solid phase filter chip and the fluid 
pumped through the filter at different flow rates.  The residence time was kept the same 
for all flow rates by pumping the samples at higher flow rate samples several times 
through the filter.  Consequently, the molecules at all flow rates would spend the same 
amount of time in proximity to the filter surface.   
Following the binding step, the filters were washed with ethanol to remove excess 
salt and impurities.  The filter was then dried by pumping air through the filter at a 
pressure of 10 psi for 2 minutes to remove residual ethanol, and then the DNA was eluted 
with 100 μl of purified water.  The quantity of DNA eluted was determined using 
fluorescence as described in later sections. 
3.2.3 Nucleic Acid Quantification Methods 
 
To determine the effectiveness of the microfluidic nucleic acid extraction, the 
quantity of nucleic acid recovered from the system must be measured.  Several methods 
have been developed to quantify the amount of nucleic acid, and three of the primary 
techniques were used to verify results in this work. 
The first method uses a spectrophotometer (Nanodrop, Wilmington, DE) to 
measure the nucleic acid absorption of UV light.  Nucleic acid has a specific UV 
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absorption spectrum, with the wavelength of interest being 260 nm.  Light is passed 
through a sample and the instrument measures the absorption and relates it to the 
concentration of nucleic acid in the sample.  Because of the specific absorption profile, 
the spectrum can also be used to determine the purity of the nucleic acid by examining 
the ratio of characteristic absorption wavelengths.  For the case of nucleic acids, a ratio of 
absorption at 260 nm to 280 nm approximately between 1.8 and 2.0 indicates sufficiently 
pure nucleic acid.  Contaminants left in the sample that absorb UV light in this spectral 
range can negatively impact readings, and care must be taken to ensure that the 
absorption spectrum from the carrier buffer be subtracted from the sample spectrum so 
that only the absorption of nucleic acids is taken into account. 
A second method of nucleic acid quantification uses fluorescent dyes.  Ribogreen 
and Picogreen (both from Invitrogen) are two such fluorescent dyes that give a linear 
response to the presence of nucleic acid and were used to quantify DNA and RNA, 
respectively.  The quantification process begins with making a standard curve by diluting 
a known concentration of DNA or RNA to concentration values that surround the region 
of interest.  The linear relation that results can be used to directly determine the nucleic 
acid concentration of an unknown sample from its level of fluorescence.  For the studies 
in this work, fluorescence was measured on a 96-well microplate reader (BioTek).    
The final quantification method used in this work is using real-time PCR.  When a 
fluorescent dye is added to the PCR reagent mix, the fluorescence emission of the 
amplified product can be monitored after every amplification cycle.  An increase in 
fluorescence indicates more strands have been duplicated, with the fluorescence making 
an exponential increase in intensity after a certain number of cycles, referred to as the 
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crossing point.  Samples that begin with a larger quantity of target nucleic acid molecules 
will have an earlier crossing point than samples with lower concentration.  Nucleic acid 
concentrations can be determined by comparing the cycle number of unknown sample 
crossing points to crossing points from known concentrations.  The instrument used for 
these measurements is the LightCycler (Roche) which monitors the amplification of the 
DNA in real time using an intercalating fluorescent dye. 
All three quantification methods have drawbacks and benefits.  
Spectrophotometry has low signal to noise ratios at low concentrations and is thus 
unreliable for samples that are dilute.  However, spectrophotometry is very rapid and 
requires little handling, modification, or extra reagents. Fluorescence readings are 
adversely affected by the presence of autofluorescing agents and chemicals that interfere 
with the binding of the dyes to the molecules of interest, but fluorescence is superb at 
handling very low concentrations.  PCR is very sensitive to contamination by PCR 
inhibitors and requires specialized equipment and strict laboratory techniques, but gives 
the best indication of the usability of the extracted sample for downstream analysis since 
much of the nucleic acid analysis for microfluidic systems includes PCR amplification of 
the target prior to detection and study. 
To ensure the accuracy of the three measurement systems described above, 
samples with known quantities of nucleic acids were compared using the three nucleic 
acid quantification methods: spectrophotometry, fluorescence, and real-time PCR 




3.2.4 Extraction Protocols 
 
 The standard chemical protocols to extract nucleic acid from a biological sample 
follow the same basic steps, independent of sample source and target molecule.  
Differences will be discussed later.  First, the sample is mixed with reagents that work to 
release the nucleic acid into solution, which usually involves the lysis of target cells.  The 
lysis buffer also contains a high concentration of a chaotropic salt (guanidinium 
thiocyanate or guanadinium hydrochloride) which will act as the selective binding agent 
in subsequent steps.  Following lysis, the sample mixture with binding salts contacts the 
solid phase silica surface.  The nucleic acid is reversibly bound to the solid phase and the 
remaining sample mixture is discarded.  A wash step is then incorporated where an 
alcohol-based solution is flowed over the solid phase to rinse off any remaining cellular 
debris or proteins that might interfere with downstream amplification or analysis.  After 
the wash step, the filter is dried, leaving only nucleic acid bound to the surface of the 
filter.  The nucleic acid is then released from the solid phase using a buffer or pure water.   
 For extracting RNA from viruses, the basic protocol is followed with a few 
additions.  Usually a stabilizing reagent (such as B-mercaptoethanol) is included with the 
lysis buffer to protect the more fragile RNA from degrading during the extraction 
process. Also, following the wash step, RNAse-free DNAse is used to digest any DNA 
that might have been extracted during the purification process, leaving only RNA for 
analysis. 
To extract RNA from bacteria, the cell lysis step also needs to include a method 
for breaking the more robust cell wall.  In this case lysozyme is used to perform an 
enzymatic process to disrupt the cell wall, enhancing the bacterial lysis process.   
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 Extracting nucleic acid from blood samples provides an additional challenge.  
Proteins that are abundant in blood samples interfere with the extraction process and 
hinder amplification of target DNA strains by PCR.  Consequently, blood extraction 
protocols begin with a proteinase digestion to remove proteins.   
3.2.5 Microfluidic Control System 
 
 Performing multiple purification protocols on a single chip is accomplished by 
using a programmable instrument that controls the on-chip flow sequence. A manifold 
that interfaces directly with the PDMS chip is mounted onto an instrument that 
electrically triggers the pneumatic operations for the on-chip fluid handling tasks.  The 
manifold is a plate embedded with barbed fittings at locations that match the pneumatic 
control ports on the bottom side of the PDMS chip (see Figure 3.6).  The chip is loaded 
onto the instrument by pushing the chip down onto the manifold, creating press-fit seals 
between the manifold fittings and pneumatic ports.  
The instrument contains 24 electrically actuated mini solenoid valves (Lee 
Company).  Control of the valve actuation is accomplished using a USB I/O digital 
controller (Elexol) connected to a PC running a LabView control program.  The LabView 
program (see Figure 3.7) has a mode for manual manipulation of fluid on the chip used 
for protocol development and troubleshooting.  Up to 4 protocol sequences can also be 
stored and implemented in an automatic mode, allowing for hands-free extraction of 
nucleic acids. 
A cleaning step was included in the program to allow for multiple tests on a single 
PDMS chip.  A solution of RBS Neutral (Sigma-Adrich) is flushed twice over the system 





Figure 3.6: Barbed fitting manifold for interface between PDMS chip and control 





Figure 3.7: Screen shot of LabView control program showing manual mode (left) and 4 
selectable automated protocol sequences (right). 
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the device allows for other disinfectants and cleaning agents to be introduced into the 
PDMS device, and the entire PDMS chip is also manifold-mounted for easy replacement 
for sensitive tests where disposable units are desired. 
3.2.6 Surface Modification 
Further optimization of the RNA extraction system was done by employing 
several surface coatings to PDMS chip to mitigate nonspecific binding of target 
molecules to the channel surfaces.  Surfaces were coated with sodium polyphosphate 
(NaPP), P-108 pluronic, P-20, and polyvinyl periladone (PVP). To perform these 
coatings, approximately 1% w/v solutions of the coating chemicals were continuously 
pumped through the extraction chip for several hours, and finally the chip filled with the 
coating solution was put in a 60 ˚C oven overnight.   Following coating of the channels, 
known 100 ng samples of RNA were extracted in the microfluidic chips and compared to 
standard extraction techniques.  
3.2.7 RNA Extraction 
Initial extraction protocols developed for the system were developed for 
extraction of RNA.  Optimization of protocol parameters progressed by adapting the 
steps contained in the RNeasy Mini Kit (Qiagen 74104).  Volumes were adjusted to keep 
mixing ratios the same and process steps were altered to incorporate chip-based pumping 
through the filter membrane instead of centrifugation. 
For initial verification of RNA extraction process parameters, known 
concentrations of RNA from a standard stock (Invitrogen) were used as the sample. An 
RNA-containing solution was placed at the sample inlet port of the PDMS device.  A 
protocol (Appendix B) for on-chip mixing of the sample with reagents was used to bind 
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the RNA to the glass filter, wash off any contaminants, and subsequently release the 
RNA in an elution of nuclease-free water. RNA extraction efficiencies were determined 
using a fluorescent Ribogreen RNA quantification kit obtained from Invitrogen.  
Fluorescence data were obtained using a 96-well plate reader (Bio-TEK).  RNA 
extraction was determined to be successful if the system produced a linear response to the 
input concentration of RNA at levels on the order of what was seen by the control 
(Qiagen commercial spin kit).  It was not anticipated that the microfluidic system would 
exceed the extraction efficiency of the commercial kit.  Rather, the innovation of the 
microfluidic system would be demonstrated in its versatility and ease of use.   
Following successful demonstration of RNA from prepurified samples from the 
system, RNA from raw biological samples was demonstrated by performing lysis and 
RNA extraction from E. Coli bacteria cells (New England Biolabs).  The cells were 
incubated in cell culture medium and growth was monitored using optical density 
measurements to ensure viability.  The E. Coli cells were then loaded into the automated 
system where they were enzymatically lysed, and RNA was extracted and quantified. 
Viral RNA was also extracted from cultured samples for the detection of Foot and 
Mouth Disease Virus (FMDV). FMDV samples in tissue culture fluid were used as the 
sample.  The extraction system was programmed according to the virus protocol listed in 
Appendix B.  The presence of extracted viral RNA was verified using spectroscopy on a 
nanodrop instrument.  Success in this case was determined by the ability to amplify the 




3.2.8 DNA Extraction 
The DNA extraction process was also established with prepurified human 
genomic DNA used as the input sample.  For these tests 100 μl samples of purified DNA 
with total DNA mass of 0, 50, 100, 200, and 400 ng were drawn into the device and 
mixed with the appropriate reagents.  Purified genomic DNA samples were provided as a 
gift from Carl Wittwer’s lab in the Department of Pathology at the University of Utah.  
Other reagents were obtained from the DNeasy Blood & Tissue Kit (69504 Qiagen).   
To perform the extraction tests, 100 µl of the known sample was drawn into a 
pipette tip, which was then inserted into the inlet port of the microfluidic chip.  The DNA 
extraction protocol (Appendix B) was initiated, pulling the sample into the microfluidic 
chip, mixing it with reagents, and extracting the DNA using the same basic binding, 
washing, and eluting steps described for RNA extraction.  The DNA extraction was 
quantified using fluorescence (Picogreen, Invitrogen) and verified by performing PCR on 
the eluate using a LightCycler instrument (Roche).  
Following verification of the ability to recover DNA, whole blood from a 
volunteer was used as the extraction sample and DNA was again extracted in the system 
and quantified using fluorescence and PCR.   The criterion for successful DNA extraction 
on the microfluidic system again was set as the ability to elicit a linear response to input 
concentration, at levels on the order of those seen in commercial standards.   
3.3 Results 
 
3.3.1 Microfluidic Chip Fabrication 
 
The microfluidic chip was successfully fabricated from PDMS.  The chip and 
control platform are shown in Figure 3.8.  Forty-one pneumatic valves are connected to 
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Figure 3.8: Completed PDMS extraction chip and control mechanism.  This compact 
device uses electric vacuum and pressure pumps along with a bank of solenoid valves to 
control a PDMS microfluidic chip.  A LabView control program allows easy adjustment 
of the protocol to handle a variety of sample inputs. 
 
the on-chip membrane valves through a manifold connector.  An on-board compressor 
and vacuum generator supply the different air pressures required to operate the on-chip 
pumps and valves.  Reagent and waste reservoirs also connect to the PDMS chip through 
tubing with barbed fittings.  A notebook computer with a LabView program control the 
processing sequence.  
Masked corona bonding was successful at selectively bonding the layers together 
except at the interface between the membrane and the valve seat.  All 41 on-chip valves 
were successful at sealing the channels for valve supply pressures greater than pumping 
pressures.  Volumes pumped by the metering pumps were measured using a micro- 
pipettor and were found to vary from the desired volume by a maximum of 5% for the 
larger pumps and a minimum of 2.7% for the smaller pumps. 
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3.3.2 Silicate Solid Phase Membrane Extraction Yield 
Characterization and Improvement 
 In order to improve the extraction efficiency of nucleic acid recovery in the 
microfluidic purification system, the effect of several parameters were adjusted and 
studied: solid phase material, flow rates, elution volume. 
3.3.2.1 Filter material 
 Two different types of filter material were used as the solid phase in the 
construction of the solid phase extraction chips: borosilicate glass microfiber filters and 
quartz filters. The borosilicate glass filters consistently had higher extraction efficiencies 
than the quartz as shown in Figure 3.9. 
3.3.2.2 Flow rates 
The effect of sample flow rate through filters made of both borosilicate glass and 
quartz was tested.  Flow rates from 1 to 50 μl/min were tested and the results are 
displayed in Figure 3.10.  Surprisingly, the lower flow rates yielded significantly less 
DNA than higher flow rates.  As the flow rate increases, from zero, the yield increases to 
a point and then seems to approach an asymptote or even decrease at the high end of the 
flow rates tested.  As this seems to disagree with results published in the literature; it is 
likely that the physical geometry of the filter chip inhibits DNA binding at low flow rates, 
perhaps by allowing the fluid to pass through a single, low-resistance flow path through 
the filter and reducing the effective surface area onto which the nucleic acid can be 
bound.  More investigation is recommended to determine the cause of the discrepancy, 
but for the current work, the flow rates achieved by the PDMS chip through the filter 








Figure 3.10: Figure showing affect of elution flow rate and different solid phase material 























































3.3.2.3 Elution volume 
When the DNA is eluted from the solid phase filter, only a certain fraction of the 
bound DNA is released.  Elution profiles have shown 5, 6 that earlier elution fractions 
have a higher concentration of nucleic acid, with the rate of nucleic acid release 
decreasing as more fluid passes the solid phase.  Elution fractions were examined by 
collecting two sets of five 35 μl (approximate) elution volumes from the extraction chip.    
The first elution volume was significantly less as the internal dead volume of the system 
had to be filled before the fluid actually went through the filter.  Results in Figure 3.11 
indicate that the peak concentration of elution happens between 15 and 70 μl with the  
amount of DNA decreasing after that.  Using only two volumes from the elution pump 
chamber will thus yield the highest concentration of nucleic acid, but additional 35 μl 




Figure 3.11: Elution fractions.  Bars represent the amount of DNA recovered with each 
successive 35 μl elution volume. 
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3.3.3 Nucleic Acid Quantification Methods 
Fluorescence, spectroscopy, and PCR crossing point analysis all correctly  
identified the amount of DNA, and can thus be used interchangeably to quantify the 
extraction results. The inclusion of samples extracted using the microfluidic system and 
their successful quantification using the different methods indicates that the system 
adequately eliminates chemical contaminants, as shown in Figure 3.12.  We see that all 
three quantification methods give strong qualitative evidence to the presence and purity 
of nucleic acids, as well as correlated, accurate quantitative measurements. 
3.3.4 Microfluidic Control System 
An instrument was constructed that contains a vacuum pump, a pressure pump, 24 
solenoid valves, and a digital I/O controller.  The controller connects via USB to a 
computer running a LabView control program. 
Protocol sequences were developed to adapt to the established chemistry used to 
extract RNA or DNA from different samples as explained above.  Table 3.1 highlights 
the differences between extraction protocols on using the automated system.    
3.3.5 Surface Modification 
Binding of the nucleic acid to the PDMS surfaces was minimized using various 
coatings and solution stabilizers.  Results from such coating tests are presented in Figure 
3.13 and extraction yields are compared to the commercial system.  RNA recovery yields 
from a sodium poly-phosphate (NaPP) coated system approached those from the 
commercial spin kit.  However, these high-yield products displayed some NaPP 
contamination that interfered with reverse-transcript polymerase chain reaction (RT-




Figure 3.12: Quantification of known quantities of DNA by three different methods 
shows a close 1:1 relation between known concentration and measured concentration for 
all measurement techniques.  Blue data points were measured with known concentrations 
spiked into a negative control extraction system output to verify that the system does not 
output trace contaminants that affect nucleic acid measurement.  The dotted line indicates 
known values. 
 
Table 3.1: Summary of protocol steps as performed by the microfluidics automated 
control program 






from E. Coli 
(with 
hybridization) RNA extraction 
Number of 
process steps  42 64 112 166 (224) 85 
Process time 
(minutes)  7.2 21.6 17.5 53.2 (62) 9.3 
Number of 
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Figure 3.13: RNA recovery yields from automated extraction system with different chip 
surface coatings. 
 
chip.   NaPP could still be beneficial for applications that do not require PCR as the 
detection method.  It was used with some success in tests performed by collaborating 
researchers (Integrated Explorations, Guelph, ON, Canada) using the microfluidic device 
to extract RNA for electrochemical detection.   
Coatings for the microfluidic chip were not used for further nucleic acid 
extraction tests because the improvement with NaPP came with an unacceptable 
incompatibility with PCR.  
3.3.6 Nucleic Acid Extraction 
3.3.6.1 Extraction of RNA 
The device was used to demonstrate successful RNA recovery at yields 































PDMS Chip Surface Coating 
Comparison
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of RNA from an RNA standard stock (Invitrogen) were used as the sample.  RNA 
extraction results are determined using a fluorescent Ribogreen RNA quantification kit 
obtained from Invitrogen.  Fluorescence data are obtained using a 96-well plate reader.   
The device was used to demonstrate successful automated recovery of prepurified 
RNA at yields approaching results attained by a commercial spin kit.  RNA is extracted 
from different starting concentrations with the microfluidic system demonstrating an 
extraction efficiency of approximately 50% compared to the commercial standard as seen 
in Figure 3.14.   
3.3.6.2 Extraction of RNA from E. Coli bacteria 
The ability of the extraction system to purify bacterial RNA was tested by using 
E. Coli 0157:H7 verotox negative bacteria as the sample.  Bacteria were obtained from  
 
 
Figure 3.14: Nucleic acid extracted from the automated microfluidic system (diamonds 
with error bars) vs a commercial kit (squares). 
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New England BioLabs and cultured in cell growth medium until they reached the 
exponential growth phase. The number of bacterial cells was measured using optical 
density techniques.  Seven million bacteria cells were used as the sample input to the 
microfluidic extraction devices.  An automated protocol listed in Appendix B performed 
the necessary steps to lyse, extract, and purify the bacterial RNA, similar to the above-
mentioned protocols, with the exception of the addition of a lysozyme to break the cell 
walls and the need for RNA protection reagents.  A total of 193 ng of RNA was 
recovered as quantified using fluorescence techniques. 
As a secondary evaluation of the ability of the system to purify RNA from 
bacteria samples, the micfoluidic system was tested at Integrated Explorations Inc., a 
biolab in Guelph, Ontario Canada.   The robust nature of the system was demonstrated by 
extracting RNA from raw biological samples (E. Coli cells) as shown in Table 3.2.  A 10-
fold increase in the number of cells proved to produce less than double the recovery of 
RNA, indicating a nonlinear relationship between amount of bacteria supplied and the 
extraction yield.  Factors that could possibly contribute to this include incomplete lysis of 
all cells, saturation of the solid phase during binding, RNA loss during washing step, or 
incomplete elution of target molecules.  Further investigation and optimization would be 
required to use the extraction chip as a quantitative measurement tool, but the current 
results are adequate for detection purposes.  
3.3.6.3 RNA extraction from virus samples 
The automated RNA extraction protocol was modified to follow established steps 
for extracting viral RNA from biological samples.  The system was tested in India by 
Indian Immunologicals LLC. Cultured FMDV samples were used as system inputs.  
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Table 3.2: RNA extraction yields from four samples of E. Coli cells that were lysed on-
chip.  Successful extraction demonstrates that the system is capable of extracting nucleic 
acid from raw biological samples 
Sample Cells Input Total RNA 
Retrieved 
E. Coli 0157:H7 70 million cells 429ng 
E. Coli 0157:H7 70 million cells 374ng 
E. Coli 0157:H7 56 million cells 253ng 
E. Coli 0157:H7  7 million cells 276ng 
 
Successful extraction was analyzed by both spectroscopic and RT-PCR detection. Table 
3.3 shows Nanodrop readings of the concentration of RNA in the 35 μl elutions.  The first 
column indicates the strain of virus and the run number identification.  The last column is 
the ratio that signifies the purity of the extracted RNA.   The 260/280 ratios in the table 
are consistently above the desired 1.8 which indicates a pure sample.   
To verify that the readings do, in fact, represent the presence of viral RNA, RT-
PCR was carried out on a plate cycler.  Figure 3.15 shows results where RNA extraction 
results from the microfluidic device (MFD) were amplified using RT-PCR and verified 
by performing gel electrophoresis.  Lane 6 is a positive control where the viral RNA was 
extracted using the Qiagen RNEasy Kit, and amplified on a plate cycler.  Lanes 1-4 have 
distinct bands in the correct location indicating that the microfluidic system successfully 
extracted viral RNA.  The weak band in lane 2 and the nonexistent band in lane 5 are 
signs that there are intermittent failures in the system.   
3.3.6.4 DNA extraction 
 The nucleic acid extraction capabilities of the microfluidic system were again 
explored by using the solid phase extraction principles to purify DNA as well.  Similar to 
RNA extraction, known quantities of DNA were obtained and used as sample inputs to 
the system.  Figure 3.16 shows the DNA extraction efficiency compared to a commercial  
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Nucleic Acid  
Conc. (µg/ml) 
A260 A280 260/280 
O IND R2/75 MFD1 69.300 1.732 0.372 4.65 
O Manisa MFD2 86.200 2.154 0.471 4.58 
O TNN 24/84 MFD3 18.900 0.473 0.103 4.58 
O TNN 24/84 MFD4 15.400 0.386 0.108 3.57 
O R2/75 MFD5 27.900 0.698 0.21 3.33 
O R2/75 MFD5 27.700 0.691 0.202 3.42 
O TNN 24/84 MFD 7 6.900 0.174 0.025 7.02 
O TNN 24/84 MFD 9 11.100 0.278 0.023 11.96 
O IND R2/75 MFD 10 7.200 0.179 0.034 5.23 
O TNN 24/84 MFD12 0.183 4.577 1.332 3.44 
O TNN 24/84 MFD13 0.031 0.78 0.31 2.52 
O TNN 24/84 MFD14 0.087 2.162 0.885 2.44 
O IND R2/75 MFD15 0.100 2.487 1.054 2.36 
O IND R2/75 MFD16 0.126 3.149 0.83 3.79 
O IND R2/75 MFD17 0.097 2.412 0.557 4.33 
O IND R2/75 MFD21 38.0 0.951 0.441 2.16 
O IND R2/75 MFD22 60.6 1.516 0.72 2.11 
O IND R2/75 MFD23 48.7 1.217 0.531 2.29 
O IND R2/75 MFD24 26.3 0.658 0.292 2.25 
 
 
Figure 3.15: Gel electrophoresis of RT-PCR amplification of extracted RNA products 
from FMDV samples using automated microfluidic system. M: 100 bp DNA Ladder, 
Lane 1 to 6 RT & PCR with standard kit. Lane 1: O TNN 24/84 MFD Run 4. Lane 2: O 
IND R2/75 MFD Run 5. Lane 3: O TNN 24/84 MFD Run 3. Lane 4: O IND R2/75 MFD 





Figure 3.16: DNA recovery using microfluidic automated nucleic acid extraction system 
compared to commercial system. 
 
laboratory kit (Qiagen DNA kit).   
To ensure that the eluent is free of contaminating chemicals introduced by the 
extraction process, nucleic acid-free control samples sent through the extraction system 
were spiked with varying amounts of purified DNA in known quantities.  Different 
amounts of whole human blood were used as the samples for nucleic acid extraction 
process, and results were again quantified using real-time PCR crossing-point analysis.  
Results were compared to extractions performed on standard commercial centrifugation 
kits.  The glass filter from one of our devices was used to replace the filter in a 
commercial spin column, and the filter from the spin column was placed in one of our 
filter casings in order to compare our solid phase filter to the one used in the commercial 
kit.  Results in Figure 3.17 show that while the extraction efficiency of the microfluidic 
device is slightly lower than commercial standards, the device is capable of extracting 





















Figure 3.17: Extraction of DNA from whole blood samples performed on-chip compared 
with standard spin kit extraction progress.  Kit 2 series indicates a spin kit test with the 
column filter replaced with the filter material used in the microfluidics.  Microfluidics 2 
is a test performed on the microfluidic chip with the filter material replaced with the 
material from the spin kit extraction columns. 
 
filters were switched, both systems extracted slightly less genetic material than what 
would be expected based on the linear response observed in other tests.   
The glass microfiber filter solid phase proved effective and is easily incorporated 
into an automated nucleic acid extraction system to extract PCR-amplifiable product 
from raw blood samples in less than 20 minutes. 
3.3.6.5 Summary of nucleic acid extraction from multiple sample types 
 A system capable of varied extraction conditions and targets is desirable for the 
creation of a versatile sample preparation device.  Table 3.4 gives a summary of total 
amounts of nucleic acid recovered from the representative extraction tests performed on 
the automated microfluidic system described in previous sections. Successful extraction 





































levels of the target NA, as opposed to having a mandated extraction efficiency or quantity 
threshold. Input amounts and conditions varied for each sample type in the table, so no 
conclusions should be drawn as to the relative quantitative ability of the system to 
process the different sample types.  Rather this table illustrates the qualitative ability of 
the system to readily extract nucleic acids form different input samples and target 
molecules in an automated fashion.   
3.4 Conclusions 
The developed NA extraction system has proven capable of handling a variety of 
sample preparation tasks in an effort to make automated nucleic acid sample preparation 
more practical and available.  Such work is a step towards a universal sample preparation 
unit that can handle many kinds of samples from viruses to tissue samples and provide 
rapid, meaningful results from a lab-on-a-chip platform. The RNA detection abilities 
were demonstrated for two main applications.  The first was the detection of E. Coli RNA 
to monitor drinking water supplies for harmful bacteria where RNA is a more appropriate 
genetic material for detection. RNA was also extracted from viral samples in tissue 
Sample Total nanograms  
NA Retrieved 
E. Coli 0157:H7 429 ng RNA 
FMDV virus 539 ng RNA 
Stock RNA 35.7 ng RNA 
Whole Blood 22.0 ng DNA 
Stock DNA  118 ng DNA 
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culture fluid to demonstrate another form of pathogen detection.  These applications will 
open the door for future pathogen screening and detection tests.   The same system was 
shown to be capable of extracting DNA from whole blood samples.  The project results 
therefore show that the developed system meets the need for fast, simple, and adaptable 
sample preparation systems.   
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OSCILLATORY FLOW PCR WITH EVAPORATION  






An oscillatory flow PCR module is presented for integration with the automated 
nucleic acid extraction system.  A disposable, multilayer polycarbonate oscillatory flow 
PCR chip is fabricated with evaporation control to keep fluid loss to under 10% over 40 
cycles.  Temperature zones on the chip are created by making contact with external 
aluminum heating blocks.  Fluid temperatures are computed using numerical simulations.  
Successful on-chip PCR is demonstrated.  
 
4.2 Introduction 
 Nucleic acid amplification is a process by which a specific sequence of a strand of 
DNA or RNA is copied multiple times to produce a larger quantity of the target sequence.  
Of the methods of amplification, PCR has grown in popularity since its inception in 
19871 because of its simplicity.  In PCR, DNA sequence primers attach to the beginning 
and end of specific sequences of nucleotide bases of a single strand of DNA in an 
annealing process that takes place at about 60 ˚C.  Elevating the temperature to an 
intermediate range around 72 ˚C activates an extension process where a polymerase 
enzyme begins at the primers and zips along the strand, inserting corresponding 
nucleotide bases to convert the single strand into a double strand of DNA. The 
temperature is then elevated above the melting temperature of the DNA at around 95 ˚C 
where the DNA molecule denatures into two single strand segments, and the process is 
repeated by following the same temperature cycle. 
 PCR is well suited for application to microfluidic devices because of the direct 
realization of several proposed microfluidic benefits: lower volumes of costly reagents 
and less thermal inertia for rapid thermal cycling.  There have been several reviews 
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published in the last decade that explore the progress made in the adaptation of PCR to 
the microchip. There are hundreds of microfluidic devices, and most microfluidic PCR 
chips can be placed into two broad categories: stationary chamber-based chips with 
integrated temperature controllers and continuous flow PCR chips.  Stationary chips offer 
good flexibility in temperature and cycle control but generally rely on more expensive 
silicon processing manufacturing techniques.  Continuous flow chips generally have 
faster temperature ramp rates because only the fluid temperature needs to change, 
eliminating the thermal inertia of surrounding chip components.  However, continuous 
flow chips have a fixed number of cycles based on channel geometry, offering little room 
for process adaptation. 
 A subset of continuous flow PCR chips that relies on oscillatory flow between 
temperature zones has arisen that attempts to include the flexibility of the stationary 
chamber devices with the low thermal mass seen in continuous flow chips.  Using this 
architecture, a fluid droplet is shuttled back and forth between different temperature 
zones on the chip.   This chapter presents a disposable polycarbonate oscillatory flow 
PCR chip that allows control over cycle times and temperatures.  The chip is integrated 
with the nucleic extraction system presented earlier by using the same instrument and 
control software for pumping the PCR droplet between temperature zones.   
 
4.3 Materials and Methods 
 The overall approach to developing an oscillatory PCR chip involved 3 stages: (1) 
Fabrication of an appropriate, cost effective chip, (2) Modification of the chip to 
overcome evaporation and sample loss, (3) Simulation of the chip to determine 
appropriate operating conditions.  The motivation and rationale for these steps follows. 
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The creation of this oscillatory PCR chip began with the choice of substrates.  
Inexpensive, disposable devices are desirable for PCR chips to reduce the risk of cross 
contamination between tests.  Plastics present fabrication cost advantages and can also 
have favorable optical properties.  However, the elevated temperatures associated with 
PCR present a stability problem for many common thermoplastics.  Polycarbonate was 
selected as the material for the chip substrate because it is optically transparent, relatively 
inexpensive, and has a sufficiently high glass transition temperature (150˚C) to withstand 
the elevated PCR annealing temperature.   
Another disadvantage to using a plastic substrate is that it is an insulator.  The 
relatively low thermal conductivity (k=0.2 w/m^2 K) impedes the heat transfer desired to 
quickly ramp the fluid temperature through the PCR thermal cycle.  This low thermal 
conductivity can be circumvented by having the heat source in contact with the fluid, but 
it is difficult to embed on-chip heaters and temperature probes and maintain low 
production costs.  Fluid temperature feedback in microchannels has been achieved using 
embedded temperature probes,2, 3 temperature dependent fluorescent dyes,4 and non-
contact interferometry.5   The difficulty in creating an inexpensive rapid plastic 
oscillatory PCR chip lies in having the ability to quickly and accurately adjust the internal 
fluid temperature using an external heat source.   
The approach used in this work mitigates the thermal insulating effect of the 
polycarbonate substrate by using thin walls in good thermal contact with external heating 
blocks.  Verification of internal fluid temperatures without direct feedback is achieved 
using numerical simulations to model the transient thermal state of the fluid.  Parameters 
such as wall thickness, material thermal properties, and external heater temperature will 
85 
 
be varied in the simulation to determine optimum chip characteristics to achieve the fluid 
temperatures needed for PCR.  Transient analysis will determine the cycle times required.  
Numerical results will be compared with measured surface and fluid temperatures 
gathered using topographical thermal imaging and embedded thermocouples.  The 
parameters developed using these models are then used experimentally and successful 
PCR is demonstrated. 
 
4.3.1 Chip Fabrication 
 Microfluidic devices for PCR need to be disposable to prevent cross-
contamination between assays.  Even trace amounts of target nucleic acids left from 
previous test runs can be amplified during the PCR process to detectable levels.  
Consequently, a simple laminated plastic chip design is used in this work to produce 
inexpensive, disposable PCR chips.  The microfluidic PCR chip is then mounted onto a 
temperature controlled heater manifold to produce the regions at temperatures required 
for PCR. 
 Two versions of the microfluidic chip were created: a simple three-layer chip with 
a serpentine chip, and a more complex version with seven layers that incorporates an 
evaporation control scheme. 
4.3.1.1 Three-layer chip fabrication 
 The microfluidic PCR chip is fabricated using three laminate layers of 
polycarbonate (Lexan FR83, Sabic Polymershapes Pittsfield, MA).  As noted earlier, 
polycarbonate is an ideal material because its glass transition temperature is well above 
the maximum temperature required for PCR (~95 ˚C), so it can be used in PCR 
applications.  Even though polycarbonate has a high glass transition temperature, 
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multilayer devices can still be easily created using heat to laminate layers together for 
rapid prototyping.  
Figure 4.1 illustrates the process of creating a multilayer polycarbonate chip.  The 
first step in chip fabrication is to cut the channel from the middle layer of polycarbonate.   
The serpentine nature of the channel geometry adds difficulty to cutting this middle layer 
as the interdigitated thin polycarbonate fingers that are produced are easily displaced 
from their intended position.  Even small finger displacement leads to device failure in 
the final chip because the small cross-section channels are easily sealed by a slight 
dislocation of the channel walls.  To prevent this dislocation, the middle layer is 
supported by a layer of adhesive during the cutting step and subsequent bonding to the 
top layer.  The adhesive tape layer is applied to a sheet of polycarbonate (a).  The  
 




polycarbonate/tape assembly is then cut using a knife plotter (Graphtec) to cut through 
the polycarbonate but leave the supporting adhesive tape layer intact (b).  The 
polycarbonate left where the fluid channel will be is then manually removed with 
tweezers, leaving an empty channel.  
Following the cutting of the fluid channel, the top layer of polycarbonate is 
thermally bonded to the middle layer using a heat press set to 175˚C (c).  The top 
polycarbonate layer is placed in contact with the polycarbonate side of the middle layer 
polycarbonate/tape assembly.  The layers are sandwiched between two pieces of smooth 
paper backing and put into the heat press, with the tape layer down. The heat press is kept 
at 175 ˚C, just over the glass transition temperature of 150 ˚C, and the two layers are 
bonded for 2 minutes with slight pressure.  This produces a good bond between the two 
layers (d), but minimizes melting to maintain the cross-section geometry of the fluid 
channel.   Access holes are then cored into the top layer for the fluid inlet and outlet (e).   
The adhesive tape support layer can then be removed from the middle layer 
because the bond between the middle and top polycarbonate layers now provides the 
support for the thin channel walls.  A bottom layer of polycarbonate is then placed in 
contact with the now exposed middle layer(f), and the chip assembly is again placed in 
the heat press in the manner stated before to bond the bottom layer to the middle(g).  The 
resulting chip has an enclosed serpentine channel in a disposable polycarbonate three-
layer chip assembly.  Custom access ports made from laser-cut acrylic are then attached 





4.3.1.2 Seven-layer evaporation control chip fabrication 
 The seven-layer version of the oscillatory flow PCR chip is fabricated using the 
same process as the three-layer device, but with two extra polycarbonate layers on the top 
and bottom surfaces shown in Figure 4.1 (j) and Figure 4.2.  The intermediate layers 
create an extra fluid layer on either side of the sample fluid layer in the middle of the 
chip.  The new fluid layers share a common inlet and outlet port.  
4.3.1.3 Chip surface inoculation 
 Following chip fabrication, the channel walls were passivated to reduce non-
specific adsorption of target molecules to the polycarbonate surface.  To passivate the 
surface of the channels in the polycarbonate chip, 0.1 % solution (w/v) of bovine serum 
albumin (BSA) was pumped through the chip at a linear rate of approximately 1 mm/sec  
 
 
Figure 4.2: Diagram of seven-layer stack for fabrication of evaporation control chip. 
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for 1 hour.  The BSA-filled chip was then incubated at 40 ˚F for 24 hours to allow BSA 
to coat all binding sites on the interior channel walls.  Prior to use in experiments, the 
BSA was pumped out and the channels dried by a flow of air. 
4.3.2 Temperature Control 
 The temperature zones for the PCR chip are controlled using three aluminum 
heater blocks.  Each block is attached to a flexible film resistive heater (Omega) and has 
an embedded thermocouple for temperature feedback.  The heater and thermocouple are 
connected to a commercial PID to monitor and control the heater block assembly 
temperature.  Voltage to the heaters is provided by a DC power supply.  The heater 
blocks are housed in a polycarbonate casing which separates the heater blocks with a 
small air gap (approximately 1 mm).  The chip is held in contact with the heater blocks 
by a polycarbonate lid layer attached with bolts.  Figure 4.3 is a photograph of the PCR  
 
 
Figure 4.3: Photograph of heater control setup. 
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chip module setup including the 3 commercial PID controllers and the chip holder 
assembly. 
4.3.3 Temperature Modeling 
 The critical step in performing PCR is ensuring that the fluid reaches the proper 
and precise temperature to facilitate the three steps of PCR: denaturation of the target 
DNA strand, annealing of the primer to the target sequence, and extension of the primer 
along the strand to create a copy of the target sequence.  The precise requirements for the 
temperature at which these steps occur dictates a rigorous analysis of the PCR chip 
temperature profile and transient analysis to optimize the PCR protocol and ensure that 
the fluid has sufficient residence time in each temperature zone to reach the proper 
temperature and complete each step in the PCR cycle.   
 To help determine the best operating parameters, first, a 3-dimensional steady 
state simulation of the thermal conditions outside the chip was performed.  This provided 
the boundary conditions needed to determine the internal temperature conditions of the 
chip.  Next, 1-dimensional, steady state solutions are determined for a range of intra-
channel fluid temperatures to yield a first approximation for the initial conditions applied 
in the transient temperature simulation.  A 1-dimensional transient numerical solution is 
then implemented to determine the minimum residence time necessary for the fluid in 
each temperature zone to reach the desired temperature.   
 
4.3.3.1 Determination of convection coefficient: h 
The first modeling step is the determination of the boundary conditions needed 
to calculate the internal fluid temperature; specifically the rate of heat leaving the top 
surface of the chip, which is dependent on the convection coefficient, h.  A common 
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method for determining h for natural convection involves using Nusselt number 
correlations based on the geometry and fluid properties.  These empirical correlations 
were generally developed for larger systems with higher Rayleigh numbers than what is 
found in the system discussed in this work.  Also, the geometric conditions of the PCR 
chip assembly require determination of the natural convection coefficient specific to this 
system. As the empirical convection coefficients are inappropriate for the conditions in 
this work, convection coefficients here are determined from 3-dimensional multiphysics 
modeling using Comsol multiphysics software.  The fluid of interest for determining the 
convection coefficient is the air above the chip surface.  The heated chip surface warms 
the air which lowers the air density, causing it to rise from buoyancy forces.  The 
geometry modeled for this system was a block of air shown in Figure 4.4. 
.   
 












The size of the block of air to be modeled was chosen based on guidance from the 
software manufacturer to place boundaries sufficiently far away from the heating surface.  
These recommended boundary distances were verified by incrementally increasing the 
size of the geometry until simulated heat flux results from the surface of interest 
remained constant.  The final geometry used for the simulations was stable with a 0.74% 
change in heat flux with a 16.7% change in geometry dimensions.  
Symmetrical flow and adiabatic boundary conditions were used on the boundary 
representing the plane of symmetry (face h).  Fixed temperatures were used at the surface 
of the chip temperature zones (faces a, b, and c). The other solid surfaces were modeled 
as thermal insulators (face i and all unlabeled faces). Those solids surfaces were 
constrained as no-slip walls for laminar flow.  The top air boundary (face g) was a heat 
outflow and a laminar outlet at ambient pressure.  The side air boundaries (faces d, e, and 
f) are set to ambient temperature and laminar inflow with no pressure. 
A body force based on the gravity acting on the temperature-induced density 
gradient was added to the air in the simulated domain to create the density driven flow in 
a natural convection environment.  The model was used to calculate I for a series of 
surface temperatures that cover the range expected for PCR experiments.  The numerical 
simulation was iterated with successively finer mesh elements until the change in the 
results varied less than 1%. 
4.3.3.2 1D steady state solution 
 For a first approximation of the temperature state in the PCR chip and the fluid 
inside the channel, a1D steady state analytical solution for a composite wall is used.  
Multiple layers are used to represent the polycarbonate layers, fluid layers, and the heater 
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block.  The thicknesses of the layers and material properties are adjusted to attain optimal 
PCR temperature control.   
The boundary conditions of the composite wall are a fixed temperature at the 
boundary representing the contact between the chip and the heater control manifold and a 
free convection boundary at the top surface exposed to room temperature.  The variable 
of interest is the temperature of the heater control manifold.  The goal is to determine 
what temperature to set as the manifold operating temperature to achieve the proper fluid 
temperature inside the channel. 
To calculate the temperature at points in the wall, we need to find the heat flux q, 
which can be determined using the thermal resistance of the entire composite wall 
coupled with the boundary conditions.  The heat equation for the composite wall is: 
 𝑞′′ = 𝑈(𝑇𝑖 − 𝑇𝑜) 
(3.1)  
where 𝑞′′ is the heat flux per unit area, 𝑇𝑖 is temperature at the inner surface of the wall, 
𝑇𝑜 is the temperature at the outer surface, and 𝑈 is the overall heat transfer coefficient in 




𝑡1 𝑘1⁄ + 𝑡2 𝑘2⁄ + ⋯ + 𝑡𝑛 𝑘𝑛⁄
 (3.2)  
where 𝑡1−𝑛 and 𝑘1−𝑛 are, respectively, the thickness and thermal conductivity of each 
layer of the PCR chip.   Any layer can be omitted in the simulation by setting the 
thickness of that layer to zero.  The temperature at the outer surface is found by 
combining the heat equation in the wall with the convection heat equation at the surface: 
 𝑞′′ = ℎ(𝑇𝑜 − 𝑇∞) 
(3.3)  
 where 𝑇∞ is the ambient temperature and h is the convection coefficient. Solving for the 
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 In the numerical simulation, the unknown temperature 𝑇𝑖  at the inner surface is given a 
guessed initial value below the expected value for the temperature at the heater 
manifold/PCR chip interface.  The temperature at the outer surface is then calculated 
from equation 3.4.  Then the heat flux 𝑞′′ can be calculated from equation 3.1, which can 
then be used to calculate the temperature at all interior points.  The average temperature 
in the middle PCR chip layer is then compared to the desired fluid temperature.   If the 
temperatures are not equal to within the desired tolerance, the guessed inner surface 
temperature is adjusted and the process repeats until the correct fluid temperature is 
reached. 
 This approach provides the steady-state temperature profile for the temperature 
through all layers of the PCR chip.  This temperature profile (like that in Figure 4.5) 
provides the initial conditions for solving the transient temperature profile to determine 
the required residence time for the fluid to reach the desired temperature.   
4.3.3.3 Transient temperature analysis 
 A transient temperature analysis of the PCR chip is performed by using a finite 





















 (3.5)  
The form often seen of this equation assumes constant properties throughout the material.  
In the case of the composite wall in this study, there are abrupt changes in the thermal 




Figure 4.5: Graph of a steady-state temperature profile solved for a 3-layer PCR chip. 
 
equation must be solved assuming that the thermal conductivity varies with x.  The 
equation can also be simplified because the planar geometry of the system allows the 
assumption that heat flows only in the x direction (normal to the chip surface) to remove 














Equation (3.6) is then converted to a finite difference approximation using a forward 
time, center space configuration. 
Aluminum Layer PC Layer Fluid 
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where σ is the temperature at position i and time m, ∆t is the time step and ∆x the 
distance between position nodes.  The variable thermal conductivity term does not use a 
center space configuration in equation 3.7.  In the composite wall configuration, using the 
centered space finite difference approximation for the thermal conductivity derivative 
does not accurately reflect the step function nature at the material interfaces.  
Consequently a backward space finite difference scheme is applied for the thermal 
conductivity derivative only. 
 Boundary conditions for the transient thermal model included a constant 
temperature at the heater block and a convection coefficient at the chip surface. 
4.3.4 Temperature Testing 
 Verification of the numerical temperature simulations was performed using 
infrared thermography.  An infrared thermal camera (FLIR 420) was used to capture the 
surface temperature of the chip.  The camera was mounted to look down at the surface of 
the PCR chip on the heater block assembly.  The chip surface was coated with a thin 
layer (approximately 30 μm) of matte black acrylic paint.  The emissivity of the paint was 
measured following the camera manufacturer’s instructions to be 0.95. 
 The temperatures of the heater blocks were adjusted from 50 ˚C to 100 ˚C and 
surface temperatures of the three-block heater assembly were recorded at 10 ˚C 
increments.  These measured surface temperatures were compared to calculated surface 
temperatures based on the simulated values for heat flux and convection coefficients.  
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 Temperature uniformity to within approximately 1°C over the surface of interest 
was desired.  Heat sink compound was employed between the heater block surface and 
the plastic chip to ensure good thermal contact and reduce temperature deviations.   
  
4.3.5 Pumping/Integration 
 The pumping method used for moving the plug of fluid between temperature 
zones uses the same metering diaphragm pumps used for the nucleic acid extraction chip.  
The pumping chip is fabricated in PDMS using the three-layer technique already 
described.  Inlet and outlet tubes from the polycarbonate PCR chip are connected to two 
ports on the pumping chip.  Diaphragm pump volumes are calculated such that a single 
stroke pushes the PCR fluid from one temperature zone to the next.  A pressurized air 
line provides an elevated back pressure to the entire pump/PCR chip system to keep the 
PCR fluid from boiling at the high temperature zone.  The pumping module for the PCR 
chip is controlled using the same instrument and software used for the nucleic acid 
extraction chip, creating an integrated extraction/amplification system. 
 
4.3.6 PCR Process Parameters 
 The ability of the oscillatory flow PCR system to amplify nucleic acids was 
demonstrated by thermal cycling a PCR sample based on an engineered, relatively short 
DNA strand obtained as a gift from BioFire Diagnostics Inc.  PCR chemistry conditions 
are indicated in Table 4.1. 





Table 4.1: Description of PCR reaction chemistry used for functional testing of 
polycarbonate oscillatory flow PCR chip 
PCR Mix Reagent Description Volume (ul) Final 
concentration 
10X dntp's 1.5 1.5 X 
30mM MgCl2 10X PCR Buffer 1 1 X 
10X LC Green 1 1 X 
10X Primer Mix (5uM) 1 0.5 μM 







total 10     
 
GTCCCTATCCTTATTGCACTACTATCTTTAGTTTACGAATATGGTTGTTTAAAT
ATGAGTCCGTGTTGACCTGAATAGCGAGG.  The forward primer used had 
sequence ATAGGTCATTCAGATTCAGTTTATGTA and the reverse primer was 
CAGGTCAACACGGACTCATATT.  The melting temperature for the sequence is 83 
˚C. 
For thermal cycling on the chip, the first temperature zone is set to 60 ˚C and the 
second and third temperature zones are both set to 95 ˚C.  The short nature of this specific 
DNA target sequence does not require an intermediate extension temperature.  The fluid 
is pumped between the two temperatures, 20 seconds at 60 ˚C and 10 seconds at 95˚C for 
each cycle.    
4.3.7 Gradient PCR 
 To verify the chemistry, eight samples of the PCR mix with template were placed 
in the wells of a 96-well plate.  The plate was thermocycled on a gradient thermocycler 
(BioRad S1000) with annealing temperatures ranging from 55 ˚C to 70 ˚C.  The plate 
underwent 40 cycles of 30 seconds at the annealing temperatures followed by 10 seconds 
99 
 
at the denaturation temperature.  Following temperature cycling, the plate was 
fluorescently imaged and analyzed using high resolution melting analysis (Light Scanner, 
Idaho Technologies). 
 
4.3.8 Melting Analysis 
 Melting analysis is performed by including a dye that fluoresces in the presence 
of DNA.  As the temperature increases to the point where the DNA denatures, the dye 
fluorescence declines rapidly.  For the 184 base-pair engineered DNA sequence, the 
melting temperature was previously calculated to be at 83 ˚C and experimentally verified 
by performing real time PCR and melting analysis on a commercial instrument (Light-
Cycler, Roche).   
  
4.3.9 Evaporation Control 
While the small volume of PCR fluid on the microscale is advantageous for 
decreasing thermal cycling times, evaporation can be a major concern.  The high 
temperatures associated with PCR (especially with the denature step) and the high surface 
to volume ratios of the droplet cause significant evaporation rates.  Also, a thin 
polycarbonate film is not a perfect barrier to water vapor. Polycarbonate has a 
permeability of 1400 barrers6 at STP, which correlates to a loss of approximately 1 μl 
(10% of a 10 μl sample) over the approximate time span of a 40 cycle PCR amplification 
run using the oscillatory flow PCR chip.  The fluid loss is expected to be even higher at 
elevated temperatures.  While information on the permeability of the polycarbonate to 
water vapor at elevated temperature is scarce, Hanada et al. indicate an approximate 10 
fold increase in water vapor transmission rates for a 40˚C increase in temperature for 120 
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μm polycarbonate membranes.7  The chip conditions at the elevated PCR temperatures 
(especially the denature temperature) predict a significant loss of fluid by permeation 
through the thin polycarbonate chip layer. 
Losing even small percentages of fluid can affect the delicate PCR chemistry 
balance and reduce PCR efficiency.  Several attempts have been made to mitigate the 
evaporation effects in microchip PCR including surrounding the droplet in oil,8 
embedding capillary channels in PDMS,9 and increasing the pressure in the channel.10  
Evaporation control was attempted using several oil-based methods in relation to the chip 
under development. 
Effective evaporation control was achieved on the polycarbonate chip by including 
an evaporation control layer on the top and bottom surfaces of the polycarbonate chip.  
The evaporation control layers are filled with water and pressurized with the same back 
pressure used in the fluid layer of the chip.   
4.3.10 Chip Coating 
 With evaporation effectively reduced, on chip DNA amplification still 
demonstrated primer-dimerization, an ineffective amplification of the target sequence.  
To improve PCR performance, the channel surface of a seven-layer evaporation control 
chip was coated with bovine serum albumin (BSA) to inoculate nonspecific binding sites 
and reduce possible target molecule or PCR reagent adsorption to the channel walls.   
 For PCR on the coated, evaporation control chip, samples were loaded and 
pumped between two temperature zones.  Forty cycles were performed with denaturation 
taking place for 10 seconds at a temperature zone set for 97.5 ˚C, annealing and extension 





4.4.1 Chip Fabrication 
 
Three-layer (Figure 4.6) and seven-layer (Figure 4.7) chips were fabricated using 
the lamination method described above.  Tubing was connected to the access ports to 
load samples and interface with the control system.  The chips held approximately 20 μl 
of fluid per temperature zone.   A laser-cut polycarbonate stack was fabricated to house 
the aluminum heater blocks for the heating module.  Figure 4.8 shows the heater module 
with wire leads for the thermocouple embedded in the aluminum and the thin film heater 
attached to the aluminum blocks.  
4.4.2 Numerical Simulations 
4.4.2.1. 3D modeling to determine convection coefficient  
 Simulations were performed on COMSOL multiphysics modeling software to 
determine the convection coefficient h for the chip geometry with multiple temperature 
zone configurations. Flow and body force profiles for one such configuration are 
visualized in Figure 4.9. 
It was observed that the middle temperature zone produced less upward flow 
relative to the neighboring temperature zones when held at the same temperature.  This  
 
 
Figure 4.6: Polycarbonate PCR chip with serpenting channels to transmit fluid to three 








Figure 4.7: Photograph of fabricated seven-layer evaporation control chip with wider 
channels for pressurized water above and below the sample fluid layer. 
 
 









Figure 4.9: Flow and body force profiles for the fluidic chip (a) Velocity magnitude 
vectors of air flow above the fluidic chip and (b) body force based on buoyancy in cross 




effect is likely due to the outside zones being exposed to inflows of cool air from three 
sides, while the middle zone is insulated on two sides by the other temperature zones.  
However, this effect was found to have negligible impact on the determined convection 
coefficient, with differences of less than 0.5% observed from zones of the same 
temperature at different locations on the chip. 
The average convection coefficient for free convection heat transfer from the chip 
surface was calculated from the heat flux per unit area q”conv leaving the surface as 
determined by the simulations. Results for h and q”conv are summarized in the first three 
columns of Table 4.2 for several chip surface temperatures.   
The small amount of heat loss from the chip surface due to natural convection 
makes radiation effects important for this system.  Indeed, calculated heat loss to the 
environment based on radiation, q”rad proves to be a larger proportion of the total heat 
flux than that caused by convection effects.  For such calculations, ambient temperatures 
(T∞) were set to 20°C.  An effective convection coefficient heff was calculated based on 
the combined heat flux q” total from both radiation and convective effects.  While heff  thus 
includes a 4th power function of temperature with the radiative heat flux, the total heat 
 
Table 4.2: Simulated and calculated values for heat flux and convection coefficients based 
on chip surface temperature. 
Surface 
Temp ˚C 
h (W/m2 K) q” conv (W/m2 
) 
q” rad (W/m2 
) 




60 6 240.6 278.5 519.1 13 
72 6.3 328.7 384.5 713.2 13.7 
90 6.8 474.6 565.8 1040.4 14.9 
100 7 559.9 678.8 1238.7 15.5 
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flux can be closely approximated by a linear function over the temperature range of 
interest.  This will be shown to be advantageous when applying boundary conditions to 
calculate the transient temperature conditions in the system. 
 
4.4.2.2 Agreement with calculated temperature 
Table 4.3 shows good agreement between thermographically measured surface 
temperature and the calculated surface temperature to within 1˚C over the range of 
interest.   
4.4.2.3 Temperature uniformity over chip surface 
Thermography temperature data from the total area of each chip temperature zone 
provide information on the temperature uniformity.  Thermal images were taken of the 
PCR chip contacting the heater blocks in two different manners: direct clamping from the 
top plate of the heater assembly, and direct clamping coupled with a layer of heat sink 
compound.   
Chips without heat sink compound were shown to demonstrate a larger variance 
in temperatures, both between temperature zones set at the same temperature, and within 
a single temperature zone.  The middle temperature zone showed better temperature 
uniformity than the outside temperature zones regardless of the presence of heat sink 
 











60  59.8 59.62 0.18 
70  69.3 69.05 0.25 
80  78.5 78.83 0.33 
90  87.9 88.59 0.69 
100  97.4 98.36 0.96 
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compound, likely due to more uniform physical contact based on the distribution of the 
clamping bolts. Figure 4.10 shows the temperature distribution on the surface with and 
without heat sink compound.  Table 4.4 summarizes the statistics for the temperature 
zones all set to the same temperature (110 ˚C) with or without heat sink compound.  
Figure 4.11 shows the simulated effects of changing geometric parameters in the system.  
The first graph shows the temperature of the sample fluid over time under heating and 
cooling conditions with changes to the thickness of the sample fluid layer.  The second 
 
 
Figure 4.10: Thermographic image showing temperature uniformity over the chip surface 
whith and without heat sink compound. 
 
Table 4.4: Effect of heat sink compound on temperature uniformity 
 
Zone 1  Zone 2  Zone 3  
Ave. Temp ˚C  
(no compound) 
100.4  106.0  98.4  
St. dev.  2.7  .4  3.3 
Ave. Temp ˚C 
(with compound) 
105.7  106.6  105.3  







Figure 4.11: Transient heating and cooling analysis of sample fluid with adjusted 
parameters. Legend in (a) indicates whether it was a heating or cooling operation and the 
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graph shows the effect of adjusting other parameters such as insulating layer thickness, 
evaporation control layer thickness, convection coefficient, etc.  These parameters each 
had a much smaller effect on the heating and cooling rates of the target fluid.  
The simulation results indicate that keeping the sample fluid layer as thin as 
possible is the best way to keep the temperature ramp rate high, with other layer 
thicknesses being less important.    The sample fluid can cool from 95˚C to the desired 
64.7 ˚C in less than .5 seconds.  Heating rates are similarly rapid. 
  
4.4.3 Evaporation Control 
Several approaches were used to reduce evaporation in the polycarbonate chip.  
First, mineral oil droplets of two different sizes (5 μl and 20 μl) were placed on either 
side of a plug of water inside a three-layer polycarbonate chip.  In another test, the top 
and bottom surfaces of a chip were coated with mineral oil.  These two efforts showed at 
best a 25% evaporation rate over 35 cycles, which was little improvement over control  
cycles (see Figure 4.12) The seven-layer evaporation control PCR chip was with  
 




































equalized pressure and humidity on either side of the polycarbonate membrane was 
shown to greatly reduce evaporation: less than 10% over as many as 60 cycles.  This 
shows that oil droplets do not work as effective evaporation deterrents for systems made 
of materials that are not good vapor barriers.  However, equalizing the pressure and 
humidity on either side of the fluid channel prevents fluid from evaporating through the 
thin channel wall of the polymer chip.   
Initial Tests of PCR amplification on the polycarbonate oscillatory flow PCR chip 
were carried out on three-layer chips.  Melting curves for amplicon produced by the chip 
are shown in Figure 4.13.  The red line (02-08-13-t1) is a PCR reaction control performed 
on commercial PCR equipment (LightCycler).  The single sudden drop in fluorescence 
and single peak in the derivative plot at the expected temperature of approximately 81°C 
indicates proper PCR amplification.   
The other lines in Figure 4.13 have multiple fluorescent drops indicated by 
multiple peaks in the derivative plot.  These peaks indicate different lengths in the strands 
of DNA molecules present.  The likely cause of this is primer-dimerization, where 
primers bind to each other and the PCR reaction replicates small primer chains, rather 
than the sequence of interest.  Dimerization can be caused by multiple factors including 
improper temperature conditions, chemical imbalances, or other forms of interference 
with the annealing or extension PCR steps. Good temperature control in the current 
system evident by the agreement between simulations and measurements indicated that 
chemical problems with the PCR reaction rather than temperature anomalies were likely 







Figure 4.13: Fluorescence and fluorescence derivative plots for high resolution melting 
analysis  The fluorescence plot (top) shows the relative intensity of the emitted 
fluorescence (y-axis) as the temperature is increased (x-axis).  The fluorescence decreases 
as the DNA strands unwind at elevated temperature.  The fluorescence derivative plot 
(bottom) is the negative derivative of the fluorescence plot.  This serves to highlight 
abrupt changes in fluorescence caused by strands of the same molecule denaturing at the 





4.4.4.1 Gradient PCR 
Melting analysis performed on the gradient PCR test samples indicates that the 
template amplified at all temperatures tested, with the highest amplification coming on 
samples with annealing at a temperature of 64.7 ˚C (see Figure 4.14).  Figure 4.14 also 
shows that the sample at the annealing temperature of 64.7 ˚C had the lowest small 
melting curve derivative peaks at other temperatures.  These other peaks indicate primer 
dimerization, where the primers attach to a section of a DNA strand (or primer) other 
than the one targeted and amplify incorrect sequences.  This condition is detrimental to 
PCR efficiency and can lead to false positive tests and is caused by temperature or 
chemical variations from the PCR recipe standard.   Based on these results, PCR for this 
molecule is effective with annealing temperatures below 64.7 ˚C.  However, all 
temperatures produced relatively minor dimerization peaks, indicating a relatively stable 
process with respect to temperature.   
4.4.4.2 Amplification on evaporation control chip 
Because temperature was ruled out as the cause of PCR reaction failures, the next 
step in producing good PCR product was to decrease evaporation rates to stabilize the 
reagent concentrations.  This was done using the seven-layer evaporation control chip. 
Following BSA coating of a seven-layer evaporation control chip, amplification was 
performed on chip with 40 cycles alternating between 95 ˚C for 10 seconds and 65 ˚C for 
20 seconds.  Successful amplification was demonstrated in 20 minutes with the proper 









Figure 4.14: High resolution melting curve and negative derivative plot of gradient PCR 






Figure 4.15: Plot of negative derivative of melting curve indicating dimer-free 
amplificaiton of  DNA template for two amplification tests. 
 
Verification that the amplicon produced by the on-chip PCR is correct was also 
carried out by performing a gel electrophoresis shown in Figure 4.16.  Bright bands were 
evident with the same number of base pairs as a positive control amplified using a water 
bath PCR method.   
Amplification of the target molecule was successful using the BSA-coated chip as 
evidenced by the electropherogram lanes 2 and 6 matching the positive control in lane 8.  
For those tests, the samples were pumped through the temperature zones and cycled by 
hand, prior to the instigation of full automation.  Though fainter, lanes 1 and 7 which 
correspond to totally automated also showed bands at the correct position.  The smearing 
of material at the bottom of the lanes indicates some primer dimerization.  The likely 




Figure 4.16: Electropherogram of DNA amplicon showing successful on-chip 
amplification. 
 
plug to regions of incorrect temperature.  However, the amplification was successful to 
the point that a melting curve would detect the presence of the target molecule. 
4.5 Conclusions 
A disposable oscillatory flow PCR chip was fabricated using multilayered 
thermally laminated polycarbonate sheets.  Temperature conditions were numerically 
simulated and experimentally verified.  A unique scheme for evaporation control was 
implemented.  Successful amplification of DNA was achieved in 40 PCR cycles in 
approximately 20 minutes.  
M   1   2  3  4  5  6   7   8  M 
M:  DNA Ladder 
Lane 1: Automated shuttle PCR 
Lane 2: Evaporation control, BSA-coated 
Lane 3: Automated shuttle PCR 
Lane 4: Not amplified  
Lane 5: negative control  
Lane 6: Evaporation control, BSA-coated 
Lane 7: Automated shuttle PCR 
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5.1 Conclusions  
  
A system for automated extraction and amplification from a variety of samples 
was developed.  The system built off of advancements to 3-layer PDMS microfluidic chip 
manufacturing to provide a device capable of complex fluid handling tasks.  The 
programmability of the device allowed for hands-off processing of nucleic acids.  A 
novel integratable shuttle PCR chip design was fabricated and successfully reduced 
evaporation rates and amplified DNA. 
Reviewing the state of the art in microfluidic nucleic acid extraction devices and 
investigating the capability to create an automated system provides several clear 
conclusions: 
 There is a need for versatile nucleic acid sample preparation systems that can 
process pure RNA or DNA from a variety of sample types in a way that can be 
done by nonexperts. 
 Three-layer PDMS components and devices were fabricated and proved to be 
effective in portable microfluidic systems with minimal external equipment. 
 The gas permeability of the membrane provided a unique pumping, bubble 
injection, and bubble removal mechanism that was effective at low-flow pumping 
in dead-end channels, trapping air bubbles, and enhancing mixing by over 40%. 
 A system was created that performs automated extraction of RNA or DNA from 
multiple sample types to make sample preparation more practical and available. 
 The Utah system is capable of extracting detectible levels of RNA from E. Coli 
bacteria and FMDV virus samples.  It likewise can be used to extract human 
genomic DNA from blood. 
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 The LabView control interface for the extraction system is capable of handling 
multiple protocols to adjust the specifics of the test to be performed. 
 A multi-layer laminate oscillatory flow PCR chip was fabricated for integration 
with the extraction system. 
 The oscillatory flow PCR scheme provides flexibility in cycle parameters while 
keeping thermal inertia low for rapid cycle times. 
 Thin polycarbonate PCR chips are prone to evaporation of sample fluid at the 
high PCR temperatures.  This evaporation can effectively be minimized by 
layering the fluid channel between layers of water pressurized equal to the sample 
fluid. 
 BSA coating of polycarbonate PCR chips prevents PCR reagent loss and permits 
dimer-free PCR amplification.   
Advancements in membrane-based component integration were instrumental in the 
selection of PDMS as the substrate for the main fluid handling chip for the nucleic acid 
extraction system.  This system has proven capable of handling a variety of sample 
preparation tasks in an effort to make automated nucleic acid sample preparation more 
practical and available.  Such work is a step towards a universal sample preparation unit 
that can handle many kinds of samples from viruses to tissue samples and provide rapid, 
meaningful results from a lab-on-a-chip platform. The RNA detection abilities were 
demonstrated for two main applications.  The first is the detection of E. Coli RNA to 
monitor drinking water supplies for harmful bacteria where RNA is a more appropriate 
genetic material for detection. RNA was also extracted from viral samples in tissue culture 
fluid to demonstrate another form of pathogen detection.  These applications will open the 
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door for future pathogen screening and detection tests.   The same system was shown to be 
capable of extracting DNA from whole blood samples.  This project satisfies global 
demand for fast, simple, and adaptable genetic testing systems.   
Detection of DNA or RNA often requires amplification through PCR. To integrate 
an amplification module with the extraction system, a disposable oscillatory flow PCR chip 
was fabricated using multilayered thermally laminated polycarbonate sheets.  Temperature 
conditions were numerically simulated and experimentally verified to produce temperature 
ramp rates as high as 60 ºC/s.  A unique scheme for evaporation control was implemented.  
Successful amplification of DNA was achieved in 40 PCR cycles in approximately 20 
minutes. 
5.2 Contributions 
Contributions made over the course of completing this project are summarized in 
the following list:  
▪ Utah system extraction unit for nucleic acid purification 
▪ Multiscale rapid prototyping PDMS casting mold creation process with 
masked corona bonding 
▪ Disposable glass fiber extraction chips 
▪ Matlab code for solving 1D steady state, and 1D transient temperature 
analysis for a fluid layer in a composite wall geometry with varying layer 
thickness and material properties 
▪ Numerical temperature analysis to determine convection coefficient for free 
convection for low Rayleigh number horizontal heated surface 
▪ Numerical temperature analysis for transient temperature profiles inside 
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multilayer, variable material microfluidic device 
▪ Novel sample evaporation control for polymer film chips to reduced 
evaporation to less than 6% over 40 cycles 
▪ LabView program for interface and control of extraction unit 
▪ Successful automated amplification of DNA template in 40 cycles in ~20 
minutes. 
5.3 Future Work 
While the system presented in this work has proven effective at extracting nucleic 
acids from multiple sample types, there are still several areas recommended for 
improvement in future iterations of the system and related research. 
Multiple sample types were used in the extraction system, but they were all in 
liquid form.  Work still needs to be done in demonstration of the current system’s ability 
to extract nucleic acids from an increased number of sample types.  Some raw sample 
mediums of interest such as stool, soil, or other solid material present difficult challenges 
for use in microfluidic systems.  Small channels could easily be blocked by excessive 
amounts of solid matter.  A filtration mechanism added to the sample input will further 
increase the versatility of the sample preparation system. Filter material or integrated 
fabricated filter features could be chosen such that large particles in impure samples 
could be screened out in the sample input well, while smaller particles and organisms that 
don’t pose the risk of channel blockage would pass through.  Demonstration of extraction 
of the target molecule from soil, food, or stool samples would indeed demonstrate 
versatility of the sample preparation system. 
Akin to filtration, a sample preconcentration step would help detect minute 
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quantities of the target molecule when it would normally get lost among the more 
prevalent DNA and RNA molecules in the sample.  As an illustration, contrast the 
demonstrated ability of the current system to extract human genomic DNA from blood 
versus the goal to find the nucleic acid signature of a scarce pathogen found in the blood 
stream.  The more plentiful genetic material from the host and other organisms in the 
blood stream would compete for solid phase binding sites.  The relatively dilute target 
(often with orders of magnitude fewer molecules) could end up fading into the 
background noise of the detection system.  A preconcentration step that would rid the 
sample of unwanted organisms or genetic material would greatly increase the specificity 
of the extraction system.    
The difficulty in implementing a preconcentration step for a system that purports 
to be agnostic to sample type is that it is not feasible to sort mechanically solely on cell 
size.  The size of the target would change based on the application as would the size of 
the unwanted background debris.  Fortunately, the control chip is already designed for 
modular components, and perhaps future work could focus on interchangeable 
mechanical filter modules with different pore sizes that can be used as the initial sample 
input section.   
The mechanical separation method seems a better fit with the goal of universality 
than other preconcentration technologies such as functionalized magnetic beads that 
attach to target molecules using specific antibodies.  While the functionalized beads 
perform well, they are highly specific to a single organism and require skilled handling 
for implementation. 
Another recommended advancement to improve the extraction system would be 
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to fully integrate the extraction and PCR modules into a single disposable device.  The 
current modular method has a benefit in that some customers may have a detection or 
analysis method that does not require amplification.  However, the sensitive nature of 
biomolecular tests begs for extreme care in avoiding cross-contamination, so reusable 
chips pose a threat.  The current PDMS extraction chip could technically be considered a 
disposable, but the materials and fabrication process are more costly than what would be 
seen in a thermoplastic chip. 
Other suggested work for the future does not include such drastic changes to the 
system’s over-all design.  Instead work can focus on realizing an expanded role of 
features already in place in the current system.  For example, the flexibility of the 
oscillatory PCR chip has not been fully explored.  The fluid temperature behavior has 
been characterized, but the ability of the system to amplify nucleic acids has only been 
proven on a single molecule.  The flexible nature of the automated PCR chip could be 
explored by performing RT-PCR on the chip.  Also longer DNA strands could be 
amplified and protocols with tighter temperature tolerances could be performed to 
explore the limits of the PCR chip.   
Finally, integration of an analysis or detection module onto the system would 
make it a complete sample-in answer-out system.  The main focus of the research to this 
point has been solely on extraction, purification, and amplification of the target, as there 
is already a wide range of devices that detect or analyze nucleic acids.  However, simply 
because the main focus is on extraction does not mean that analysis cannot be an offered 
module for the system.  Analysis could be integrated with the PCR module, where real 
time monitoring of fluorescence of the PCR process would be able to indicate the 
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presence of amplified target.  The capability to perform such analysis would require little 
more than a light transmitter and fluorescence detector.  LabView, which already controls 
the instrument function, can readily control and monitor the detection equipment at the 
same time. 
These recommendations will further improve a system that has demonstrated an 
ability to simplify nucleic acid extraction.  This system has demonstrated improvements 
in components and subsystems that can be used by nonexperts.  It has also proven to be a 
practical technology, used by nonexperts in the field in Canada and India, far from the 
supervision of the system creators.  As the future work continues to expand on the past 
demonstrations of versatile nucleic acid extraction, this sample preparation system will be 
on the cutting edge of the transition to a commercially viable technology as it benefits 
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PROTOCOLS FOR EXTRACTION OF NUCLEIC ACID USING  




Stepwise Control Sequences Used to Perform Nucleic Acid Extraction 
Table B.1 Protocol steps for basic extraction of DNA 
Step Description Solenoid Time (ms) Hexcode 
1 
TE buffer pretreatment of filter 
4         003000 80:00:00 
2   4 19       006000 80:00:40 
3   19 10 11 12   003000 00:E0:40 
4   10 11 12 21   030000 00:E0:01 
5   21 14       003000 00:02:01 
6   14         005000 00:02:00 
7 Load buffer pretreatment 1         003000 10:00:00 
8   1 16       006000 10:08:00 
9   16 10 12     003000 00:A8:00 
10   10 12 21     030000 00:A0:01 
11   21 14       003000 00:02:01 
12   14         005000 00:02:00 
13 Sample mixing with load buffer 4         003000 80:00:00 
14   4 15       006000 80:04:00 
15   15 1       003000 10:04:00 
16   15 1 16     007000 10:0C:00 
17   15 16 11 7 8 003000 0C:4C:00 
18 Mixing 16 22 11 7 8 005000 0C:48:02 
19   22 11 7 8   007000 0C:40:02 
20   22 7 8     003000 0C:00:02 
21   7 8 16     008000 0C:08:00 
22   7 8 22     008000 0C:00:02 
23   7 8 16     008000 0C:08:00 
24   7 8 22     015000 0C:00:02 
25 Pass through filter 22 9 8 12   003000 08:90:02 
26   9 8 12 21   060000 08:90:01 
27 Out to waste 21 14       003000 00:02:01 
28   14         010000 00:02:00 
29 Wash 2         003000 20:00:00 
30   2 16       006000 20:08:00 
31   16 10 12     003000 00:A8:00 
32   10 12 21     030000 00:A0:01 
33 out to waste 21 14       003000 00:02:01 
34   14         010000 00:02:00 
35 Dry 5 12 14     060000 01:82:00 
36 Elution 4         003000 80:00:00 
37   4 19       008000 80:00:40 
38   19 10 11 6   003000 02:60:40 
39   10 11 6 20   030000 02:60:80 
40   20 11 12     003000 00:C0:80 
41 
  
11 12       015000 00:C0:00 




Table B.2 Protocol steps for basic extraction of RNA 
Step Description Solenoid Time (ms) Hexcode 
1 
Mix 50uL of sample with 100uL of BPR (becomes 
Mix 1) 3         002000 40:00:00 
2 draw sample into CH3 3 17       005000 40:00:10 
3   17 6 7     002000 06:00:10 
4 move to CH4 6 7 15     008000 06:04:00 
5   3 15       002000 40:04:00 
6   3 17 15     005000 40:04:10 
7   17 6 7 15   002000 06:04:10 
8   6 7 15     006000 06:04:00 
9 
Introduce and mix 350uL of B-ME-RLT to MIX 2 
(now Mix 3) 15 1       003000 10:04:00 
10 draw RLT 15 1 16     010000 10:0C:00 
11 prepare to move Lysed sample to CH5 15 16 11 7 8 003000 0C:4C:00 
12 Move mixtures to CH5, prepare to move to CH6 11 16 7 8 22 010000 0C:48:02 
13   16 7 8 22   003000 0C:08:02 
14 move all mixtures to CH6 7 8 22     010000 0C:00:02 
15 move to CH5 7 8 16     003000 0C:08:00 
16 move all mixtures to CH6 7 8 22     003000 0C:00:02 
17 move to CH5 7 8 16     003000 0C:08:00 
18 move all mixtures to CH6 7 8 22     003000 0C:00:02 
19 move to CH5 7 8 16     003000 0C:08:00 
20 move all mixtures to CH6 7 8 22     015000 0C:00:02 
21 
Introduce and mix 250uL of Ethanol to MIX 3 
(now Mix 4) 22 4       002000 80:00:02 
22 Draw EtOH to CH4 22 4 15     006000 80:04:02 
23   22 15 11     002000 00:44:02 
24 send to CH5 22 16 11     007000 00:48:02 
25   22 16 7 8   002000 0C:08:02 
26 move to CH6 22 7 8     006000 0C:00:02 
27 move to CH5 16 7 8     003000 0C:08:00 
28 Move to CH6 22 7 8     003000 0C:00:02 
29 FWD 7 8 16     003000 0C:08:00 
30 BCKWD 7 8 22     003000 0C:00:02 
31 FWD 7 8 16     003000 0C:08:00 
32 BCKWD 7 8 22     010000 0C:00:02 
33 Pass MIX 4 through the silica filter (prepare) 22 9 8 12   001000 08:90:02 
34 Pass MIX 4 through the silica filter (prepare) 22 9 8 12   002000 08:90:02 
35 FWD 21 9 8 12   020000 08:90:01 
36 BCKWD 22 9 8 12   020000 08:90:02 
37 FWD 21 9 8 12   045000 08:90:01 
38 Send waste to waste bottle…..Ready…. 21 14       003000 00:02:01 
39 Go! 14         020000 00:02:00 
40 drain to waste 14 5 12     008000 01:82:00 
41   14 12       003000 00:82:00 
42 
  
14         001000 00:02:00 
43 Make sure everything is empty (open valves) 8 9 12     003000 08:90:00 
44 
Open ch 7 
8 9 12 21   010000 08:90:01 
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Table B.2 continued 
Step Description Solenoid Time (ms) Hexcode 
45 Send waste to waste bottle…..Ready…. 21 14       003000 00:02:01 
46 Go! 14         008000 00:02:00 
47 drain to waste 14 5 12     008000 01:82:00 
48   14 12       003000 00:82:00 
49   14         001000 00:02:00 
50 
Introduce 350uL of rpe buffer and pass thru silica 
filter 3         003000 40:00:00 
51 draw rpe 3 16       010000 40:08:00 
52 prepare to move thru filter 16 10 12     002000 00:A8:00 
53 GO! 21 10 12     025000 00:A0:01 
54 Send waste to waste bottle 21 14       003000 00:02:01 
55   14         010000 00:02:00 
56 drain to waste 14 5 12     008000 01:82:00 
57   14 12       003000 00:82:00 
58   14         001000 00:02:00 
59 
Introduce 350uL of Rpe buffer and pass thru silica 
filter 3         003000 40:00:00 
60 draw Rpe 3 16       010000 40:08:00 
61 prepare to move thru filter 16 10 12     003000 00:A8:00 
62 GO! 21 10 12     025000 00:A0:01 
63 Send waste to waste bottle 21 14       003000 00:02:01 
64   14         010000 00:02:00 
65 drain to waste 14 5 12     060000 01:82:00 
66   14 12       003000 00:82:00 
67   14         001000 00:02:00 
68 Elution Step 4         3000 80:00:00 
69   4 19       8000 80:00:40 
70   19 10 11 6   3000 02:60:40 
71   10 11 6 20   3000 02:60:80 
72   19 10 11 6   3000 02:60:40 
73   10 11 6 20   3000 02:60:80 
74   19 10 11 6   3000 02:60:40 
75   10 11 6 20   3000 02:60:80 
76   19 10 11 6   3000 02:60:40 
77   10 11 6 20   3000 02:60:80 
78   19 10 11 6   3000 02:60:40 
79   10 11 6 20   3000 02:60:80 
80   19 10 11 6   3000 02:60:40 
81   10 11 6 20   6000 02:60:80 
82   20 10 11 6 12 4000 02:E0:80 
83 output 20 11 12     3000 00:C0:80 
84   11 12       6000 00:C0:00 





Table B.3 Protocol steps for extraction of RNA from viral samples 
Step Description Solenoid Time (ms) Hexcode 
1 
Mix 50uL of sample with 100uL of BPR 
(becomes Mix 1) 3 6 7     003000 00:00:00 
2 draw sample into CH3 3 6 7 15 17 008000 46:00:00 
3   17 6 7 15   003000 46:04:10 
4 move to CH4 6 7 15     008000 06:04:10 
5   3 15       003000 06:04:00 
6   3 17 15     005000 40:04:00 
7   17 6 7 15   003000 40:04:10 
8   6 7 15     009000 06:04:10 
9 
Introduce and mix 350uL of B-ME-RLT to 
MIX 2 (now Mix 3) 15 1       003000 06:04:00 
10 draw RLT 15 1 16     010000 10:04:00 
11 prepare to move Lysed sample to CH5 15 16 11 7 8 003000 10:0C:00 
12 
Move mixtures to CH5, prepare to move to 
CH6 11 16 7 8 22 010000 0C:4C:00 
13   16 7 8 22   003000 0C:48:02 
14 move all mixtures to CH6 7 8 22     010000 0C:08:02 
15 move to CH5 7 8 16     003000 0C:00:02 
16 move all mixtures to CH6 7 8 22     003000 0C:08:00 
17 move to CH5 7 8 16     003000 0C:00:02 
18 move all mixtures to CH6 7 8 22     003000 0C:08:00 
19 move to CH5 7 8 16     003000 0C:00:02 
20 move all mixtures to CH6 7 8 22     020000 0C:08:00 
21 
Introduce and mix 250uL of Ethanol to MIX 
3 (now Mix 4) 22 4       003000 0C:00:02 
22 Draw EtOH to CH4 22 4 15     010000 80:00:02 
23   22 15 11     003000 80:04:02 
24 send to CH5 22 16 11     010000 00:44:02 
25   22 16 7 8   003000 00:48:02 
26 move to CH6 22 7 8     006000 0C:08:02 
27 move to CH5 16 7 8     006000 0C:00:02 
28 Move to CH6 22 7 8     006000 0C:08:00 
29 FWD 7 8 16     006000 0C:00:02 
30 BCKWD 7 8 22     006000 0C:08:00 
31 FWD 7 8 16     006000 0C:00:02 
32 BCKWD 7 8 22     020000 0C:08:00 
33 
Pass MIX 4 through the silica filter 
(prepare) 22 9 8 12   001000 0C:00:02 
34 
Pass MIX 4 through the silica filter 
(prepare) 22 9 8 12   003000 08:90:02 
35 FWD 21 9 8 12   030000 08:90:02 
36 BCKWD 22 9 8 12   030000 08:90:01 
37 FWD 21 9 8 12   060000 08:90:02 
38 Send waste to waste bottle…..Ready…. 21 14       003000 08:90:01 
39 Go! 14         030000 00:02:01 
40 drain to waste 14 5 12     008000 00:02:00 
41   14 12       003000 01:82:00 




Table B.3 continued 
Step Description Solenoid Time (ms) Hexcode 
43 
Make sure everything is empty (open 
valves) 8 9 12     003000 00:02:00 
44 Open ch 7 8 9 12 21   025000 08:90:00 
45 Send waste to waste bottle…..Ready…. 21 14       003000 08:90:01 
46 Go! 14         015000 00:02:01 
47 drain to waste 14 5 12     008000 00:02:00 
48   14 12       003000 01:82:00 
49   14         001000 00:82:00 
50 
Introduce 350uL of RW1 buffer and pass 
thru silica filter 2         003000 00:02:00 
51 draw RW1 2 16       010000 20:00:00 
52 prepare to move thru filter 16 10 12     003000 20:08:00 
53 GO! 21 10 12     010000 00:A8:00 
54   16 10 12     010000 00:A0:01 
55   21 10 12     010000 00:A8:00 
56   16 10 12     010000 00:A0:01 
57   21 10 12     040000 00:A8:00 
58 Send waste to waste bottle 21 14       003000 00:A0:01 
59   14         025000 00:02:01 
60 drain to waste 14 5 12     008000 00:02:00 
61   14 12       003000 01:82:00 
62   14         001000 00:82:00 
63 
Introduce 350uL of RW1 buffer and pass 
thru silica filter 2         003000 00:02:00 
64 draw RW1 2 16       010000 20:00:00 
65 prepare to move thru filter 16 10 12     003000 20:08:00 
66 GO! 21 10 12     040000 00:A8:00 
67 Send waste to waste bottle 21 14       003000 00:A0:01 
68   14         010000 00:02:01 
69 drain to waste 14 5 12     008000 00:02:00 
70   14 12       003000 01:82:00 
71   14         001000 00:82:00 
72 
Introduce 350uL of rpe buffer and pass thru 
silica filter 3         003000 00:02:00 
73 draw rpe 3 16       010000 40:00:00 
74 prepare to move thru filter 16 10 12     003000 40:08:00 
75 GO! 21 10 12     010000 00:A8:00 
76   16 10 12     010000 00:A0:01 
77   21 10 12     010000 00:A8:00 
78   16 10 12     010000 00:A0:01 
79   21 10 12     040000 00:A8:00 
80 Send waste to waste bottle 21 14       003000 00:A0:01 
81   14         010000 00:02:01 
82 drain to waste 14 5 12     008000 00:02:00 
83   14 12       003000 01:82:00 
84   14         001000 00:82:00 
85 
Introduce 350uL of Rpe buffer and pass 
thru silica filter 3         003000 00:02:00 
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Table B.3 continued 
Step Description Solenoid Time (ms) Hexcode 
86 draw Rpe 3 16       010000 40:00:00 
87 prepare to move thru filter 16 10 12     003000 40:08:00 
88 GO! 21 10 12     010000 00:A8:00 
89   16 10 12     010000 00:A0:01 
90   21 10 12     010000 00:A8:00 
91   16 10 12     010000 00:A0:01 
92   21 10 12     040000 00:A8:00 
93 Send waste to waste bottle 21 14       003000 00:A0:01 
94   14         010000 00:02:01 
95 drain to waste 14 5 12     008000 00:02:00 
96   14 12       003000 01:82:00 
97   14         001000 00:82:00 
98 
Introduce 350uL of Rpe buffer and pass 
thru silica filter 3         003000 00:02:00 
99 draw Rpe 3 16       010000 40:00:00 
100 prepare to move thru filter 16 10 12     003000 40:08:00 
101 GO! 21 10 12     40000 00:A8:00 
102 
Send waste to waste bottle 
21 14       3000 00:A0:01 
103   14         10000 00:02:01 
104 
Long drying time (in current MF protocol its 
step #40) 5 12 21 14   120000 00:02:00 
105   14 12 21     3000 01:82:01 
106   14         6000 00:82:01 
107 Elution Step 4         3000 00:02:00 
108   4 19       8000 80:00:00 
109   19 10 11 6   3000 80:00:40 
110   10 11 6 20   5000 02:60:40 
111   19 10 11 6   5000 02:60:80 
112   10 11 6 20   5000 02:60:40 
113   19 10 11 6   5000 02:60:80 
114   10 11 6 20   5000 02:60:40 
115 
  
19 10 11 6   5000 02:60:80 
116   10 11 6 20   5000 02:60:40 
117   19 10 11 6   5000 02:60:80 
118   10 11 6 20   5000 02:60:40 
119 
  
19 10 11 6   5000 02:60:80 
120 
  
10 11 6 20   5000 02:60:40 
121   20 10 11 6 12 6000 02:60:80 
122 output 20 11 12     3000 02:E0:80 
123   11 12       10000 00:C0:80 
124 end           3000 00:C0:00 





Table B.4 Steps for extracting RNA from bacteria samples. 
Step Description Solenoid Time (ms) Hexcode 
1 
Open Valve for Port I5 
3         3000 40:00:00 
2 draw 50 ul sample into CH3 3 17       10000 40:00:10 
3   17 6 7     3000 06:00:10 
4 move to CH4 6 7 15     10000 06:04:00 
5 Open valve for port I4 15 2       3000 20:04:00 
6 draw 50 ul BPR to ch3 15 2 17     5000 20:04:10 
7 move BPR to CH4 15 17 6 7   10000 06:04:10 
8   15 6 7     3000 06:04:00 
9 Open valve for port I4 15 2       3000 20:04:00 
10 draw 50 ul BPR to ch3 15 2 17     5000 20:04:10 
11 move to CH4 15 17 6 7   10000 06:04:10 
12   15 6 7     3000 06:04:00 
13 
Incubate Mixture for 5min at room temp 
(20-25C) 15         300000 00:04:00 
14 
Open valve for port I3 
15 1       3000 10:04:00 
15 Draw in 50 ul Lysozyme to ch3 15 1 17     3000 10:04:10 
16 move to CH4 15 17 6 7   6000 06:04:10 
17   15 6 7     3000 06:04:00 
18 
Open valve for port I3 
15 1       3000 10:04:00 
19 Draw in 50 ul Lysozyme to ch3 15 1 17     3000 10:04:10 
20 move to CH4 15 17 6 7   6000 06:04:10 
21   15 6 7     3000 06:04:00 
22 
Incubate Mix 2 for 10min at ROOM TEMP 
(20-25C) 15         600000 00:04:00 
23 
Open valve for port I8 
15 1       3000 10:04:00 
24 draw 350 ul RLT 15 1 16     10000 10:0C:00 
25 prepare to move Lysed sample to CH5 15 16 11 7 8 3000 0C:4C:00 
26 
Move mixtures to CH5, prepare to move 
to CH6 11 16 7 8 22 10000 0C:48:02 
27   16 7 8 22   3000 0C:08:02 
28 move all mixtures to CH6 7 8 22     10000 0C:00:02 
29 move to CH5 7 8 16     3000 0C:08:00 
30 move all mixtures to CH6 7 8 22     20000 0C:00:02 
31 
Open valve for port I7 
22 4       3000 80:00:02 
32 Draw 250 ul EtOH to CH4 22 4 15     10000 80:04:02 
33   22 15 11     3000 00:44:02 
34 send to CH5 22 16 11     10000 00:48:02 
35   22 16 7 8   3000 0C:08:02 
36 move to CH6 22 7 8     6000 0C:00:02 
37 move to CH5 16 7 8     6000 0C:08:00 
38 Move to CH6 22 7 8     20000 0C:00:02 
39 
Pass MIX 4 through the silica filter 
(prepare) 22 9 8 12   3000 08:90:02 
40 FWD 21 9 8 12   30000 08:90:01 
41 BCKWD 22 9 8 12   30000 08:90:02 
42 FWD 21 9 8 12   60000 08:90:01 
43 Send waste to waste bottle…..Ready…. 21 14       3000 00:02:01 
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Table B.4 continued 
Step Description Solenoid Time (ms) Hexcode 
44 Go! 14         30000 00:02:00 
45 
Make sure everything is empty (open 
valves) 8 9 12     3000 08:90:00 
46 Open ch 7 8 9 12 21   25000 08:90:01 
47 Send waste to waste bottle…..Ready…. 21 14       3000 00:02:01 
48 Go! 14         15000 00:02:00 
49 Open valve for I9 2         3000 20:00:00 
50 draw 350 ul RW1 2 16       10000 20:08:00 
51 prepare to move thru filter 16 10 12     3000 00:A8:00 
52 GO! 21 10 12     40000 00:A0:01 
53 Send waste to waste bottle 21 14       3000 00:02:01 
54   14         25000 00:02:00 
55 Open Valve for I1 4         3000 80:00:00 
56 Draw water…. 4 19       5000 80:00:40 
57 prepare to send to CH5 19 10 11     3000 00:60:40 
58 send to CH5 10 11 16     10000 00:68:00 
59   7 8 16     3000 0C:08:00 
60 send to CH6 7 8 22     10000 0C:00:02 
61   22 13       3000 00:01:02 
62 send to CH7 13 21       10000 00:01:01 
63   21 14       3000 00:02:01 
64 send to waste 14         15000 00:02:00 
65 Repeat RW1 well rinse 4         3000 80:00:00 
66 Draw water…. 4 19       5000 80:00:40 
67   19 10 11     3000 00:60:40 
68 send to CH5 10 11 16     10000 00:68:00 
69   7 8 16     3000 0C:08:00 
70 send to CH6 7 8 22     10000 0C:00:02 
71   22 13       3000 00:01:02 
72 send to CH7 13 21       20000 00:01:01 
73   21 14       3000 00:02:01 
74 send to waste 14         40000 00:02:00 
75 
Open valve for port I2 
1         3000 10:00:00 
76 draw DNAse into ch2 1   18     10000 10:00:20 
77   18 3       3000 40:00:20 
78 Draw RDD to CH5 18 3 16     10000 40:08:20 
79 DNAse moves to CH5 18 16 9 10   3000 00:38:20 
80   16 9 10     10000 00:38:00 
81   16 10 12     3000 00:A8:00 
82 move to filter 10 12 21     40000 00:A0:01 
83   21 14       3000 00:02:01 
84 junk to waste 14         20000 00:02:00 
85 
Incubate DNAse 1 on silica filter for 5min 
20-25C 0         300000 00:00:00 
86 
Open valve for port I2 
1         3000 10:00:00 
87 draw DNAse ONLY 1   18     10000 10:00:20 
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Table B.4 continued 
Step Description Solenoid Time (ms) Hexcode 
88   18 3       3000 40:00:20 
89 draw RDD ONLY 18 3 16     10000 40:08:20 
90 DNAse moves to CH5 18 16 9 10   3000 00:38:20 
91   16 9 10     10000 00:38:00 
92   16 10 12     3000 00:A8:00 
93 move to filter 10 12 21     45000 00:A0:01 
94   21 14       3000 00:02:01 
95 junk to waste 14         20000 00:02:00 
96 
Incubate DNAse 1 on silica filter for 5min 
20-25C 0         300000 00:00:00 
97 Open valve to port I9 2         3000 20:00:00 
98 draw RW1 2 16       10000 20:08:00 
99   16 10 12     3000 00:A8:00 
100 send to filter 21 10 12     40000 00:A0:01 
101 Send waste to waste bottle 21 14       3000 00:02:01 
102   14         15000 00:02:00 
103 Open valve for port I6 4         3000 80:00:00 
104 draw RPE 4 17       10000 80:00:10 
105   17 6 7     3000 06:00:10 
106 move to CH4 6 7 15     10000 06:04:00 
107 Draw EtOH to CH4 4 15       10000 80:04:00 
108   15         3000 00:04:00 
109   15 11       3000 00:44:00 
110 send to CH 5 11 16       8000 00:48:00 
111   16 10 12     3000 00:A8:00 
112 send through filter 10 12 21     25000 00:A0:01 
113   21 14       3000 00:02:01 
114 send to waste 14         15000 00:02:00 
115 
Suck in 50uL of RPE buffer and 200uL of 
ethanol and mix 4         3000 80:00:00 
116 draw RPE 4 17       10000 80:00:10 
117   17 6 7     3000 06:00:10 
118 move to CH4 6 7 15     10000 06:04:00 
119 Draw EtOH to CH4 4 15       10000 80:04:00 
120   15         3000 00:04:00 
121   15 11       3000 00:44:00 
122 send to CH 5 11 16       8000 00:48:00 
123   16 10 12     3000 00:A8:00 
124 send through filter 10 12 21     25000 00:A0:01 
125   21 14       3000 00:02:01 
126 send to waste 14         15000 00:02:00 
127 
Suck in 50uL of RPE buffer and 200uL of 
ethanol and mix 4         3000 80:00:00 
128 draw RPE 4 17       10000 80:00:10 
129   17 6 7     3000 06:00:10 
130 move to CH4 6 7 15     10000 06:04:00 
131 Draw EtOH to CH4 4 15       10000 80:04:00 
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Table B.4 continued 
Step Description Solenoid Time (ms) Hexcode 
132   15         3000 00:04:00 
133   15 11       3000 00:44:00 
134 send to CH 5 11 16       8000 00:48:00 
135   16 10 12     3000 00:A8:00 
136 send through filter 10 12 21     25000 00:A0:01 
137   21 14       3000 00:02:01 
138 send to waste 14         15000 00:02:00 
139 
Suck in 50uL of RPE buffer and 200uL of 
ethanol and mix 4         3000 80:00:00 
140 draw RPE 4 17       10000 80:00:10 
141   17 6 7     3000 06:00:10 
142 move to CH4 6 7 15     10000 06:04:00 
143 Draw EtOH to CH4 4 15       10000 80:04:00 
144   15         3000 00:04:00 
145   15 11       3000 00:44:00 
146 send to CH 5 11 16       8000 00:48:00 
147   16 10 12     3000 00:A8:00 
148 send through filter 10 12 21     25000 00:A0:01 
149   21 14       3000 00:02:01 
150 send to waste 14         15000 00:02:00 
151 
Long drying time (in current MF protocol 
its step #40) 5 12 21 14   300000 01:82:01 
152   12 21 14     3000 00:82:01 
153   21 14       3000 00:02:01 
154   14         3000 00:02:00 
155   0         3000 00:00:00 
156 open valve for port I1 4         3000 80:00:00 
157 Draw in 150 ul H20 4 19       10000 80:00:40 
158 open valves 19 10 11 6   3000 02:60:40 
159 pass through filter 10 11 6 20   15000 02:60:80 





Table B.5 Protocol steps for extracting DNA from blood samples 
Step Description Solenoid Time (ms) Hexcode 
1 proteinase solution in  4         002000 80:00:00 
2   4 17       010000 80:00:10 
3   17 7 6     002000 06:00:10 
4   7 8 15     010000 0C:04:00 
5 100 ul sample in 15 3       002000 40:04:00 
6   15 3 17     004000 40:04:10 
7   15 17 6 7   002000 06:04:10 
8   15 6 7     004000 06:04:00 
9   15 3       002000 40:04:00 
10   15 3 17     004000 40:04:10 
11   15 17 6 7   002000 06:04:10 
12   15 6 7     004000 06:04:00 
13 50 ul AL buffer in  15 2       002000 20:04:00 
14   15 2 17     010000 20:04:10 
15   15 17 6 7   002000 06:04:10 
16   15 6 7     010000 06:04:00 
17 Mix 17 6 7     003000 06:00:10 
18   15 6 7     003000 06:04:00 
19   17 6 7     003000 06:00:10 
20   15 6 7     003000 06:04:00 
21   17 6 7     003000 06:00:10 
22   15 6 7     003000 06:04:00 
23 incubate for 10 minutes 15         600000 00:04:00 
24 input 100 ul of etoh 15 1       002000 10:04:00 
25   15 1 17     004000 10:04:10 
26   15 17 6 7   002000 06:04:10 
27   15 6 7     004000 06:04:00 
28   15 1       002000 10:04:00 
29   15 1 17     004000 10:04:10 
30   15 17 6 7 11 002000 06:44:10 
31   15 6 7 16 11 004000 06:4C:00 
32   6 7 11 16   004000 06:48:00 
33   16 11       002000 00:48:00 
34 Mix 15 11       003000 00:44:00 
35   16 11       003000 00:48:00 
36   15 11       003000 00:44:00 
37   16 11       003000 00:48:00 
38 Pass through filter 16 13 12     002000 00:89:00 
39   13 12 21     040000 00:81:01 
40   21 14       002000 00:02:01 
41   14         002000 00:02:00 
42   14 5 12     004000 01:82:00 
43   14         008000 00:02:00 
44 wash with AW1 1         002000 10:00:00 
45   1 16       015000 10:08:00 
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Table B.5 continued 
Step Description Solenoid Time (ms) Hexcode 
46   16 13 12     002000 00:89:00 
47   12 13 21     040000 00:81:01 
48   21 14       002000 00:02:01 
49   14         010000 00:02:00 
50 wash with AW2 2         002000 20:00:00 
51   2 16       015000 20:08:00 
52   16 13 12     002000 00:89:00 
53   12 13 21     040000 00:81:01 
54   21 14       002000 00:02:01 
55   14         010000 00:02:00 
56 Dry 5 12 14     120000 01:82:00 
57 elution 4         002000 80:00:00 
58   4 19       004000 80:00:40 
59   19 10 11 6   002000 02:60:40 
60   10 11 6 20   010000 02:60:80 
61   20 11 6 10 12 001000 02:E0:80 
62   20 11 12     002000 00:C0:80 
63   11 12       003000 00:C0:00 






MATLAB CODE FOR 1D STEADY STATE AND 1D TRANSIENT  
SIMULATIONS FOR INTERNAL TEMPERATURES  
OF MULTILAYER POLYCARBONATE  
OSCILLATORY FLOW PCR CHIP 
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    clear T Tinitial Ts a1 alpha chamberx cs ks r rhos 
thicknesses times ts u uold x; 
    it1=it1+1; 
    tmax = 1; % end time 
ti=.01; % time interval to sample answer for plotting "every ti 
seconds" 
Tinf=20+273; % Ambient Air Temperature 
Tgoal=273+60; % temperature you want the fluid to reach 
h0=.0628*(Tgoal-273)+9.2062+10; % Set convection coefficient 
q0=18*(Tgoal-273)-571.21 %heat flux from 3d simulation w/m^2 
fluidtemp=273+95; % Set temperature of fluid to be pumped into 
channel 
tins1=0.000127; % Thickness of insulating layer on top of chip 
tinsw1=0.000126; % Thicnkess of top water layer 
ttop=.000127; % Thicnkess of top chip layer 
tmid=.000127; % Thicnkess of middle chip layer *sample* 
tbot=.000127; % Thicnkess of bottom chip layer 
tbotw=.000127; % thickness of bottom water layer 
tbot2=0.000127; % thickness of bottom insulating layer 
tins2=0.0003; % Thicnkess of layer between chip and heater 
%heater between these two layers 
tins3=0; % Thicnkess of layer under heater 





% alternative number of points per layer 
if min(thicknesses)>0 
    si=min(thicknesses)/points; % space increment calculate 
else 
    si=.00002;  % manually set alternative space increment 
end 
 
x=[0:si:sum(thicknesses)];  % x vector distance through chip 
 























%Assign properties to layers 
kins1=kpolyc; rins1=rpolyc; cins1=cpolyc; 
kinsw1=kh20;   rinsw1=rh20;   cinsw1=ch20; 
ktop=kpolyc; rtop=rpolyc; ctop=cpolyc; 
kmid=kh20;   rmid=rh20;   cmid=ch20; 
kbot=kpolyc; rbot=rpolyc; cbot=cpolyc; 
kbotw=kh20;   rbotw=rh20;   cbotw=ch20; 
kbot2=kpolyc; rbot2=rpolyc; cbot2=cpolyc; 
kins2=kalum; rins2=ralum; cins2=calum; 
kins3=kpdms; rins3=rpdms; cins3=cpdms; 
 




ks(find(x>=tins3 & x<tins3+tins2))=kins2; 
ks(find(x>=tins3+tins2 & x<tins3+tins2+tbot2))=kbot2; 

















rhos(find(x>=tins3 & x<tins3+tins2))=rins2; 
















cs(find(x>=tins3 & x<tins3+tins2))=cins2; 
cs(find(x>=tins3+tins2 & x<tins3+tins2+tbot2))=cbot2; 


















% while err>0.001   
% n1=n1+1; 
% Th=Th+tcorr; 




% % the thermal resistance to find q across the entire chip 
% %Ttop=(h0*Tinf+Th*U)/(h0+U); % find temperature on boundary 
with ambient 
% q=q0; % calculate heat flux 
%  










% % fluid chamber is the area of interest, find the average 
temperature of 






q=q0; % calculate heat flux 
 










% fluid chamber is the area of interest, find the average 
temperature of 













%Plot the calculated temperature profile in the chip 
ts=[0,tins2,tins2+tbot2,tins2+tbot2+tbotw,tins2+tbot2+tbotw+tbot,
tins2+tbot2+... 
    tbotw+tbot+tmid,tins2+tbot2+tbotw+tbot+tmid+ttop,tins2+tbot2+
tbotw+tbot+tmid+ttop+tinsw1,... 
    tins2+tbot2+tbotw+tbot+tmid+ttop+tinsw1+tins1]; 
    
Ts=[Th,Tins2,Tbot2,Tbotw,Tbot,Tmid,Ttop,Tinsw1,Tins1]; 
plot(ts,Ts) 
disp(['heatertemp temp: ',num2str(Th-273)]) 
disp(['chamber temp: ',num2str(Tchamber-273), ' +/- ', 
num2str(Tchamber-Tmid)]) 
disp(['surface temp: ',num2str(Ttop-273)]) 
% %% 







% %% transient 
% --- Define constants and initial condition 
 
 
L = max(x); % length of domain in x direction 
alpha=ks./(rhos.*cs); 
 
nx = length(x); % number of nodes in x direction 
dx = L/(nx-1); 
nt = ceil(max(alpha)*tmax/(.5*dx.^2)); % number of time steps 
 
 






r = alpha.*dt./dx.^2; 
plot(r) 






    if Tinitial(k-1)>=Tins2; 
        Tinitial(k)=Tinitial(k-1)-(Th-Tins2)/(tins2/dx); 
    elseif Tinitial(k-1)>=Tbot2; 
        Tinitial(k)=Tinitial(k-1)-(Tins2-Tbot2)/(tbot2/dx); 
        elseif Tinitial(k-1)>=Tbotw; 
        Tinitial(k)=Tinitial(k-1)-(Tbot2-Tbotw)/(tbotw/dx); 
        elseif Tinitial(k-1)>=Tbot; 
        Tinitial(k)=Tinitial(k-1)-(Tbotw-Tbot)/(tbot/dx); 
    elseif Tinitial(k-1)>=Tmid; 
        Tinitial(k)=Tinitial(k-1)-(Tbot-Tmid)/(tmid/dx); 
    elseif Tinitial(k-1)>=Ttop; 
        Tinitial(k)=Tinitial(k-1)-(Tmid-Ttop)/(ttop/dx); 
    elseif Tinitial(k-1)>=Tinsw1; 
        Tinitial(k)=Tinitial(k-1)-(Ttop-Tinsw1)/(tinsw1/dx); 
    else Tinitial(k-1)>=Tins1; 
        Tinitial(k)=Tinitial(k-1)-(Tinsw1-Tins1)/(tins1/dx); 
         
     
    end 




% --- Loop over time steps 
t = 0; 
% u = Th*ones(1,length(x));% initial condition 
% u(1)=Th; 
% u(length(u))=Tinf; 



















    uold = u; % prepare for next step 
    t = t + dt; 
     
    for j=2:nx-1 
            %u(j) = r(j-1)*uold(j-1) + r2(j)*uold(j) + 
r(j)*uold(j+1); 
            u(j)=dtdx2*alpha(j)*(uold(j-1)-
2*uold(j)+uold(j+1))+uold(j)+... 
                alpha(j)*dtdx2/(ks(j)*2)*(ks(j+1)-
ks(j))*(uold(j+1)-uold(j)); 
           
              
    end 
     
    u(end)=(ks(end)/(h0*dx)*uold(nx-
1)+Tinf)/(1+ks(end)/(h0*dx));  %convective boundary condition 
    % vectorized 
%     u(2:nx-1)=dtdx2.*alpha(2:nx-1).*(uold(1:nx-2)-2*uold(2:nx-
1)+uold(3:nx))+uold(2:nx-1)+... 
%         alpha(2:nx-1).*dtdx2./(ks(2:nx-1)*4).*(ks(3:nx)-
ks(1:nx-2)).*(uold(3:nx)-uold(1:nx-2)); 
%  
%     u(end)=(ks(end)/(h0*dx)*uold(nx-
1)+Tinf)/(1+ks(end)/(h0*dx));  %convective boundary condition 
    
              
    if mod(t,ti)<mod(t-dt,ti) 
        index1=round(t/ti)+1 
        chambertemp(it1,index1)=mean(u(chamberx)); 
      
        times(index1)=t; 
        T(index1,:)=u; 
        plot(x,u-273) 
        title('1-D Transient Temperature, Multiple Layers') 
        xlabel('Distance (m)') 
        ylabel('Temperature (K)') 
        axis([0, L, 50, 100]) 
        text(0,60,['Time: ', num2str(t)]) % display time on graph 
        text(0,65,['Fluid temp: ', num2str(chambertemp(index1)-
273)]) % display time on graph 
        M(round(t/ti))=getframe(gcf); 





        %pause(.01) 
        if abs(mean(u(chamberx))-Tchamber)<.1 
            break % break when the fluid reaches the desired 
temperature 
        end 





















save(filename,'chambertemp', '-ascii')  
load filename 
%% 
